info icon

Thyroiditis, ILD-related definition

THYROIDITIS_ILD

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 E03.80, E06
  • Hospital discharge: ICD-9 2448A
  • Hospital discharge: ICD-8 245
  • Cause of death: ICD-10 E03.80, E06
  • Cause of death: ICD-9 2448A
  • Cause of death: ICD-8 245

2 out of 7 registries used, show all original rules.

4993

4. Check minimum number of events

None

4993

5. Include endpoints

None

4993

6. Filter based on genotype QC (FinnGen only)

4993

Control definitions (FinnGen only)

Control exclude
ILD_SYST_AUTO_DISEASES

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 4993 4088 905
Unadjusted period prevalence (%) 1.21 1.39 0.40
Median age at first event (years) 45.71 44.68 50.38

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
4516
Matched controls
45157
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
104
Kela drug reimbursment
Thyroid insufficiency
11.5
323.0
1382
1672
H03AA01
ATC
levothyroxine sodium; systemic
18.2
323.0
3506
7246
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
9.0
323.0
1827
3172
E06.9
ICD-10 Finland
Thyroiditis, unspecified
283.6
323.0
389
15
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
413.3
323.0
2466
132
E06.1
ICD-10 Finland
Subacute thyroiditis
192.4
323.0
700
43
E06.3
ICD-10 Finland
Autoimmune thyroiditis
152.7
323.0
620
47
E03.89
ICD-10 Finland
Other specified hypothyroidism
9.9
273.1
583
669
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
7.8
230.6
567
814
E03
ICD-10 Finland
Other hypothyroidism
5.3
192.3
647
1388
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
9.3
186.0
407
477
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
7.9
179.5
436
606
H04AA01
ATC
glucagon; nasal, parenteral
9.4
172.2
372
425
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.9
165.3
596
1367
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.9
160.9
579
1324
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
7.6
159.6
395
562
H03BB01
ATC
carbimazole; oral
5.9
156.0
467
862
T89
ICPC
Diabetes insulin dependent
6.7
153.6
418
681
A10AA01
ATC
NA
8.7
152.2
344
423
T86
ICPC
Hypothyroidism/myxoedema
6.0
146.6
432
780
2448A
ICD-9 Finland
Acquired hypothyroidism, Other specified acquired hypothyroidism[HYPOTHYREOSIS POST THYREOIDITIDEM]
+∞
140.3
134
*
A10AA02
ATC
NA
7.2
139.4
356
528
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
7.1
135.6
350
527
E06.0
ICD-10 Finland
Acute thyroiditis
180.5
134.3
140
8
A10AE05
ATC
insulin detemir; parenteral
5.1
134.1
454
963
24599
ICD-8 Finland
Thyroiditis, Unspecified
+∞
130.9
125
*
A10AE04
ATC
insulin glargine; parenteral
3.9
129.3
581
1629
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
9.7
127.5
269
292
H02AB06
ATC
prednisolone; systemic
2.1
121.9
2176
13779
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
8.8
119.3
267
321
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
6.0
116.6
344
617
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
108.8
104
*
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
8.6
108.4
245
299
24509
ICD-8 Finland
Thyroiditis, Unspecified
+∞
106.7
102
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.3
97.4
1081
5397
103
Kela drug reimbursment
Diabetes, insulin-treated
2.2
92.7
1116
5768
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
7.6
86.3
211
291
E10
ICD-10 Finland
Type 1 diabetes mellitus
7.3
80.7
201
285
SPAT1262
SPAT
Handing over of treatment supplies
2.4
79.8
820
3890
H3600, E103
ICD-10 Finland
NA
10.8
79.5
157
150
A10AE06
ATC
insulin degludec; parenteral
5.5
79.3
245
462
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
79.1
1442
8759
E03.8
ICD-10 Finland
Other specified hypothyroidism
29.8
77.6
105
36
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
37.1
76.3
98
27
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
6.6
75.3
203
322
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
53.4
74.4
89
17
24500
ICD-8 Finland
Thyroiditis, Subacuta de Quervain
+∞
74.2
71
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
73.9
1254
7374
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.5
73.2
373
1140
E06.4
ICD-10 Finland
Drug-induced thyroiditis
+∞
73.1
70
*
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
7.3
71.3
178
253
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
70.5
1708
11347
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
11.6
70.4
134
119
E06.2
ICD-10 Finland
Chronic thyroiditis with transient thyrotoxicosis
352.6
69.8
70
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.3
66.0
256
616
H02AB09
ATC
hydrocortisone; systemic
5.7
64.2
192
348
H02AB07
ATC
prednisone; oral
2.3
61.2
656
3141
E06.5
ICD-10 Finland
Other chronic thyroiditis
606.2
60.9
60
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.7
59.6
444
1750
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
8.2
59.3
136
170
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
8.8
58.7
129
150
XCK10
NOMESCO Finland
Photography of fundus of eye
2.6
58.4
474
1963
L40.0
ICD-10 Finland
Psoriasis vulgaris
11.9
57.2
107
92
K51.5
ICD-10 Finland
Left sided colitis
89.8
56.0
62
7
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
10.7
55.4
109
104
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
54.5
1657
11542
A02BC02
ATC
pantoprazole; systemic
1.6
53.1
2711
21675
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
6.1
51.8
146
246
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
7.6
50.6
122
165
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
11.2
50.6
97
88
C07AA05
ATC
propranolol; systemic
1.8
50.2
960
5760
24503
ICD-8 Finland
Thyroiditis, Chronica
+∞
50.1
48
*
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
22.6
47.5
69
31
BAA60
NOMESCO Finland
Total thyroidectomy
4.2
47.2
189
468
24501
ICD-8 Finland
Thyroiditis, Subacuta alia
+∞
46.9
45
*
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
47.2
46.1
56
12
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.9
45.5
302
1105
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.6
45.4
351
1408
C07AB07
ATC
bisoprolol; oral
1.6
44.2
1666
12105
177
Kela drug reimbursment
Insulin glargine 300 U / ml
5.1
44.2
144
289
E03.82
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
37.8
44.1
56
15
A07EC02
ATC
mesalazine; oral, rectal
5.6
43.8
131
238
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
43.5
690
3851
R53
ICD-10 Finland
Malaise and fatigue
1.8
43.3
887
5410
R06.0
ICD-10 Finland
Dyspnoea
1.7
43.2
988
6239
UJF32
NOMESCO Finland
Coloscopy
1.8
42.5
937
5845
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
42.4
1039
6694
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
4.9
42.0
141
293
H3601, E103
ICD-10 Finland
NA
7.7
41.8
99
131
105
Kela drug reimbursment
Adrenal cortical hypofunction
22.5
41.4
60
27
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
8.5
40.9
91
109
H3603, E103
ICD-10 Finland
NA
7.3
40.4
99
138
H36.00
ICD-10 Finland
Diabetic background retinopathy
6.9
40.2
103
153
24409
ICD-8 Finland
Myxoedema, (hypothyreosis) NUD
24.6
39.7
56
23
N03AX16
ATC
pregabalin; oral
1.7
39.2
961
6170
R51.80
ICD-10 Finland
Headache
1.8
38.9
709
4144
J01MA02
ATC
ciprofloxacin; systemic
1.6
38.6
1457
10493
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
38.4
900
5699
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
9.8
38.1
78
81
K50.9
ICD-10 Finland
Crohn disease, unspecified
380.6
38.1
38
*
B03BA03
ATC
hydroxocobalamin; parenteral
3.0
37.6
233
815
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
37.5
734
4387
J01DB01
ATC
cefalexin; oral
1.6
37.1
3563
31616
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
9.3
36.1
76
83
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
360.2
36.0
36
*
A07EC01
ATC
sulfasalazine; oral, rectal
2.6
36.0
280
1125
K50.8
ICD-10 Finland
Other Crohn disease
+∞
35.5
34
*
L40.5
ICD-10 Finland
Arthropathic psoriasis
29.7
35.1
47
16
R03AC02
ATC
salbutamol; inhalant
1.5
34.7
2288
18531
R50.9
ICD-10 Finland
Fever, unspecified
1.9
34.5
568
3192
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
34.2
535
2951
E06
ICD-10 Finland
Thyroiditis
36.2
33.7
43
12
K90.0
ICD-10 Finland
Coeliac disease
3.3
33.7
175
541
P01BA02
ATC
hydroxychloroquine; oral
2.3
33.5
341
1574
H02AA02
ATC
fludrocortisone; oral
9.2
33.2
70
77
N06AX21
ATC
duloxetine; oral
1.9
33.2
500
2719
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
4.8
33.1
114
244
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
32.4
352
1670
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
8.7
32.0
70
82
K51.8
ICD-10 Finland
Other ulcerative colitis
319.3
31.9
32
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.5
31.9
273
1155
N03AX12
ATC
gabapentin; oral
1.8
31.6
620
3690
L04AX01
ATC
azathioprine; systemic
4.0
31.6
129
327
J01DA01
ATC
[U] cefalexin; systemic
1.4
31.4
2631
22154
A10AA03
ATC
NA
7.3
30.9
75
104
K29.4
ICD-10 Finland
Chronic atrophic gastritis
4.6
30.8
110
245
N02AX02
ATC
tramadol; systemic, rectal
1.5
30.0
1559
11892
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
29.9
723
4580
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
2.7
29.3
210
804
A07EA06
ATC
budesonide; oral, local oral
4.6
29.2
103
227
J02AC01
ATC
fluconazole; systemic
1.4
29.0
1916
15308
M07.3
ICD-10 Finland
Other psoriatic arthropathies
66.4
28.9
33
5
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
66.4
28.9
33
5
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.0
28.7
413
2205
J01FF01
ATC
clindamycin; systemic
1.5
28.6
1053
7431
A02BC05
ATC
esomeprazole; systemic
1.5
28.5
1603
12395
M25.5
ICD-10 Finland
Pain in joint
1.5
28.4
1178
8541
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
28.4
232
957
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
28.2
1603
12413
J01FA10
ATC
azithromycin; systemic
1.4
28.1
2564
21712
E0000UV
ATC
NA
1.4
27.8
1624
12634
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
27.4
361
1860
N02BE01
ATC
paracetamol; systemic, rectal
1.5
27.4
3648
33176
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
+∞
27.1
26
*
J01AA02
ATC
doxycycline; systemic
1.4
26.6
3232
28713
SPAT1263
SPAT
Sampling
1.4
26.4
1754
13947
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
26.3
1018
7248
G35
ICD-10 Finland
Multiple sclerosis
36.9
26.1
33
9
C03CA01
ATC
furosemide; systemic
1.6
26.1
824
5588
109
Kela drug reimbursment
Multiple sclerosis
+∞
26.1
25
*
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
73.1
25.8
29
*
A02BC03
ATC
lansoprazole; oral
1.5
25.7
1095
7955
P01AB01
ATC
metronidazole; oral, rectal
1.4
25.7
1681
13310
H02AB04
ATC
methylprednisolone; systemic
1.7
25.6
566
3483
H062, E050
ICD-10 Finland
NA
21.9
25.6
37
17
107
Kela drug reimbursment
Pernicious anaemia
4.8
25.6
86
181
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
25.5
1097
7983
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
4.3
25.4
96
227
G47.3
ICD-10 Finland
Sleep apnoea
1.6
25.3
696
4550
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
25.3
319
1613
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
5.1
25.1
80
159
J01FA06
ATC
roxithromycin; oral
1.4
24.9
1628
12862
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
24.7
696
4578
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
24.7
694
4560
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
43.1
24.5
30
7
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
6.4
24.2
64
101
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
5.2
24.1
76
149
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
24.1
1951
15986
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
+∞
24.0
23
*
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
23.9
395
2213
A10AB06
ATC
insulin glulisine; parenteral
5.4
23.8
72
135
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.7
23.8
107
297
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
12.0
23.7
43
36
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
23.6
539
3346
E03.3
ICD-10 Finland
Postinfectious hypothyroidism
19.6
23.4
35
18
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
23.4
984
7106
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
4.5
23.4
84
190
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
23.3
723
4867
J01MA12
ATC
levofloxacin; systemic
1.6
23.3
623
4038
G44.2
ICD-10 Finland
Tension-type headache
1.7
23.2
582
3705
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
22.9
1205
9102
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
+∞
22.9
22
*
E66.01
ICD-10 Finland
Obesity due to excess calories
1.9
22.8
362
1998
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
22.7
1653
13248
N06AX11
ATC
mirtazapine; oral
1.4
22.7
1250
9524
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
22.6
890
6328
N06AB04
ATC
citalopram; systemic
1.5
22.3
868
6151
R00.2
ICD-10 Finland
Palpitations
1.9
22.2
325
1741
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
9.7
22.2
45
47
B81
ICPC
Anaemia vit B12/folate deficiency
2.9
22.2
136
475
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.7
22.0
99
275
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
22.0
536
3386
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
3.0
21.8
126
422
AA1AD
NOMESCO Finland
CT of head and brain
1.5
21.8
786
5478
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.1
21.8
258
1269
M45
ICD-10 Finland
Ankylosing spondylitis
17.1
21.7
34
20
H36.01
ICD-10 Finland
Diabetic maculopathy
5.1
21.6
69
138
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
21.5
335
1836
R01AD09
ATC
mometasone; nasal
1.4
21.5
1914
15824
E05.89
ICD-10 Finland
Other thyrotoxicosis
11.2
21.4
40
36
D51.0
ICD-10 Finland
Vitamin B12deficiency anaemia due to intrinsic factor deficiency
8.9
21.3
45
51
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
21.2
965
7066
R42
ICD-10 Finland
Dizziness and giddiness
1.5
21.2
795
5583
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.1
21.2
238
1148
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.8
20.9
134
482
M54.5
ICD-10 Finland
Low back pain
1.4
20.7
1295
10068
K50.1
ICD-10 Finland
Crohn disease of large intestine
110.5
20.6
22
*
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
20.4
2003
16770
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
20.4
668
4543
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
11.3
20.4
38
34
H43.1
ICD-10 Finland
Vitreous haemorrhage
3.2
20.3
107
337
R01AD08
ATC
fluticasone; nasal
1.4
20.1
1179
9051
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.7
20.0
449
2767
M79.1
ICD-10 Finland
Myalgia
1.6
20.0
535
3459
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
4.5
19.9
71
160
MAA00
NOMESCO Finland
Amniocentesis
2.8
19.8
132
487
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.0
19.8
250
1265
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
19.7
900
6579
A07AA02
ATC
nystatin; oral
2.1
19.7
241
1204
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
200.8
19.6
20
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
19.5
386
2288
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
19.5
658
4505
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
19.5
523
3384
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
19.4
667
4585
R11
ICD-10 Finland
Nausea and vomiting
1.8
19.4
321
1797
CKC12
NOMESCO Finland
Photocoagulation of retina
2.4
19.4
167
711
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.2
19.4
213
1016
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
19.2
187
844
K50.0
ICD-10 Finland
Crohn disease of small intestine
46.2
19.2
23
5
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
19.2
324
1825
UKC02
NOMESCO Finland
Cystoscopy
1.7
19.2
439
2721
R13
ICD-10 Finland
Dysphagia
2.1
19.2
233
1163
RD210
NOMESCO Finland
NA
3.3
19.0
96
294
M13.9
ICD-10 Finland
Arthritis, unspecified
2.0
18.7
248
1280
D07AD01
ATC
clobetasol; topical
1.6
18.6
544
3598
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
18.5
405
2476
A02BC01
ATC
omeprazole; systemic
1.4
18.3
1006
7609
M79.6
ICD-10 Finland
Pain in limb
1.4
18.3
1380
11026
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
18.2
286
1573
N06AA09
ATC
amitriptyline; systemic
1.7
18.2
368
2197
WX110
NOMESCO Finland
Local anesthesy
1.3
18.1
2876
25688
J01CA04
ATC
amoxicillin; systemic
1.4
18.0
3502
32272
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
6.4
18.0
47
74
C01BD01
ATC
amiodarone; systemic
3.1
18.0
98
317
T90
ICPC
Diabetes non-insulin dependent
1.5
18.0
685
4809
C10AX09
ATC
ezetimibe; oral
1.8
18.0
327
1890
2449X
ICD-9 Finland
Acquired hypothyroidism, Unspecified hypothyroidism
11.5
18.0
33
29
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
17.9
570
3843
XQ800
NOMESCO Finland
Prick test
1.8
17.8
341
2002
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
17.8
1764
14691
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
13.7
17.7
30
22
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
17.7
2096
17910
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
17.6
2986
26868
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
17.4
348
2070
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
17.4
1289
10246
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
28.9
17.4
23
8
C10AA05
ATC
atorvastatin; oral
1.4
17.3
1127
8771
L04AB04
ATC
adalimumab; parenteral
5.0
17.3
55
111
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
17.3
2231
19277
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
2.8
17.2
114
419
R06AE07
ATC
cetirizine; oral
1.3
17.2
1833
15405
N05CF01
ATC
zopiclone; oral
1.4
17.1
1132
8827
A02BA02
ATC
ranitidine; systemic
1.5
17.1
669
4723
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
6.9
17.1
42
61
171
Kela drug reimbursment
Degludekinsuliini
7.7
17.0
39
51
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.8
16.9
312
1809
6481B
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Thyroid dysfunction[HYPOTHYREOSIS IN GRAVIDITATE]
17.4
16.9
26
15
C07AB02
ATC
metoprolol; systemic
1.5
16.8
638
4473
T85
ICPC
Hyperthyroidism/thyrotoxicosis
5.9
16.7
46
78
A01AB09
ATC
miconazole; local oral
1.7
16.7
334
1988
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.7
16.6
390
2429
C09AA05
ATC
ramipril; oral
1.5
16.6
686
4895
M14.5*E03.9
ICD-10 Finland
Arthropathy in hypothyroidism (E00-E03+)
9.2
16.6
34
37
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
16.6
1295
10368
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
5.7
16.6
47
83
D07AC13
ATC
mometasone; topical
1.4
16.5
1058
8195
A02BC04
ATC
rabeprazole; oral
1.7
16.5
331
1968
Z3231
NOMESCO Finland
Registered nurse
1.4
16.5
993
7612
L04AB01
ATC
etanercept; parenteral
4.4
16.5
60
139
A04
ICPC
Weakness/tiredness general
1.6
16.5
489
3238
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
16.4
636
4474
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
16.3
1808
15236
E66.8
ICD-10 Finland
Other obesity
1.9
16.2
233
1241
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
16.2
371
2299
Z96.4
ICD-10 Finland
Presence of endocrine implants
10.4
16.1
31
30
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
16.1
246
1342
SPAT1310
SPAT
Counselling related to known health issue
1.3
16.0
1234
9843
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
15.8
309
1823
E03.1
ICD-10 Finland
Congenital hypothyroidism without goitre
12.2
15.8
28
23
A10AD04
ATC
insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
6.6
15.8
40
61
L28
ICPC
Limited function/disability (L)
1.6
15.8
491
3291
A07EA02
ATC
hydrocortisone; rectal
5.9
15.7
43
73
O36.6
ICD-10 Finland
Maternal care for excessive fetal growth
2.2
15.7
165
774
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
15.7
1394
11365
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
15.6
346
2119
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
15.6
589
4122
SPAT1097
SPAT
Recording of ECG
1.6
15.6
474
3160
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
15.5
590
4138
C10AA07
ATC
rosuvastatin; oral
1.4
15.4
745
5478
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
15.4
1619
13510
R52.9
ICD-10 Finland
Pain, unspecified
1.7
15.4
320
1926
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
2.4
15.3
125
520
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
3.0
15.3
90
309
D05AX52
ATC
calcipotriol, combinations; topical
2.4
15.2
125
523
SPAT1301
SPAT
No procedures
1.3
15.1
1163
9263
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.2
15.1
151
691
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.7
15.1
104
394
M05BA04
ATC
alendronic acid; oral
1.8
15.1
265
1514
SPAT1153
SPAT
Removal of sutures
1.4
15.0
1093
8626
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.2
15.0
79
251
J01FA09
ATC
clarithromycin; systemic
1.3
15.0
1279
10343
E000001
ATC
NA
1.4
15.0
770
5723
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
15.0
980
7603
N30.0
ICD-10 Finland
Acute cystitis
1.5
15.0
556
3873
R07.0
ICD-10 Finland
Pain in throat
1.8
15.0
253
1425
R20.2
ICD-10 Finland
Paraesthesia of skin
1.8
14.7
255
1450
C09AA02
ATC
enalapril; systemic
1.5
14.7
557
3895
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
8.7
14.7
31
36
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
14.7
2329
20496
N06AB10
ATC
escitalopram; oral
1.4
14.6
842
6392
L03AB07
ATC
interferon beta-1a; parenteral
+∞
14.6
14
*
164
Kela drug reimbursment
Fingolimod
+∞
14.6
14
*
ZXD05
NOMESCO Finland
Urgent procedure
1.3
14.6
1172
9388
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
14.6
306
1848
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.2
14.5
145
665
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
14.5
407
2657
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
14.5
298
1787
L80
ICD-10 Finland
Vitiligo
7.5
14.4
33
44
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
14.4
446
2986
XF404
NOMESCO Finland
Ambulatory ECG
1.7
14.3
304
1841
R03DC03
ATC
montelukast; oral
1.4
14.2
646
4690
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
14.2
370
2373
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4.0
14.1
56
142
UJD02
NOMESCO Finland
Gastroscopy
2.1
14.1
164
806
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.5
14.1
499
3438
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.6
14.1
428
2847
A03FA02
ATC
cisapride; oral, rectal
1.7
14.1
274
1615
ZXE00
NOMESCO Finland
One hour or less
1.3
14.1
1543
12912
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.2
14.0
136
618
M65.3
ICD-10 Finland
Trigger finger
2.0
13.9
176
894
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
13.9
1496
12476
K02.1
ICD-10 Finland
Caries of dentine
1.3
13.9
2321
20490
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
13.7
243
1393
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
10.5
13.7
26
25
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
10.5
13.7
26
25
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
13.7
349
2225
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
13.6
2727
24602
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.9
13.6
206
1122
L01
ICPC
Neck symptom/complaint
1.5
13.5
528
3715
K51
ICD-10 Finland
Ulcerative colitis
34.1
13.5
17
5
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.7
13.5
287
1739
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
13.5
1037
8235
B01AB05
ATC
enoxaparin; parenteral
1.3
13.4
1046
8321
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
6.0
13.4
36
60
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
13.4
457
3123
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
13.4
527
3715
C01CA24
ATC
epinephrine; parenteral
1.7
13.4
261
1543
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
11.5
13.3
24
21
L01BB02
ATC
mercaptopurine; oral
8.1
13.3
29
36
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
13.3
472
3254
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.3
13.2
118
516
A11CC03
ATC
alfacalcidol; systemic
2.9
13.2
78
270
S18
ICPC
Laceration/cut
1.3
13.2
1446
12072
R06AX27
ATC
desloratadine; oral
1.3
13.2
1131
9123
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
3.0
13.2
76
258
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
13.1
240
1390
K30
ICD-10 Finland
Functional dyspepsia
1.6
13.0
388
2568
Z01.2
ICD-10 Finland
Dental examination
1.3
13.0
1679
14308
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
13.0
2136
18759
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
4.5
13.0
45
101
R4180
NOMESCO Finland
Podiatric therapy
4.5
13.0
45
101
M79.7
ICD-10 Finland
Fibromyalgia
2.1
12.9
148
721
R60.0
ICD-10 Finland
Localized oedema
1.6
12.9
347
2239
L88
ICPC
Rheumatoid/seropositive arthritis
2.3
12.8
121
543
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.6
12.8
89
340
N05AH04
ATC
quetiapine; oral
1.4
12.8
615
4507
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
12.8
595
4334
M54.2
ICD-10 Finland
Cervicalgia
1.7
12.7
263
1582
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
1.7
12.6
247
1461
N04BC05
ATC
pramipexole; oral
1.7
12.6
238
1392
2452A
ICD-9 Finland
Thyroiditis, Chronic lymphocytic thyroiditis
70.1
12.6
14
*
L17
ICPC
Foot/toe symptom/complaint
1.3
12.6
901
7067
R52.2
ICD-10 Finland
Other chronic pain
2.2
12.5
129
603
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
12.5
360
2365
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
3.0
12.5
72
244
353
Kela drug reimbursment
Cladribine and fingolimod
+∞
12.5
12
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.7
12.5
82
302
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.2
12.5
128
596
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
12.5
674
5044
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
3.7
12.5
53
144
Z45.1
ICD-10 Finland
Adjustment and management of infusion pump
20.1
12.4
18
9
A05AA02
ATC
ursodeoxycholic acid; oral
2.9
12.4
75
264
C03DA01
ATC
spironolactone; oral
1.6
12.4
298
1869
M01AH05
ATC
etoricoxib; oral
1.3
12.4
2268
20128
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
3.9
12.4
50
130
D02AE01
ATC
carbamide; topical
1.8
12.3
232
1355
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.6
12.3
289
1800
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
12.3
1037
8333
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
4.4
12.3
43
98
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
12.1
294
1849
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.9
12.1
166
873
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.3
12.0
112
499
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
12.0
1327
11057
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
2.8
12.0
76
276
6480A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus
4.2
12.0
44
105
H05.2
ICD-10 Finland
Exophthalmic conditions
8.7
12.0
25
29
H57.1
ICD-10 Finland
Ocular pain
2.1
12.0
127
601
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
12.0
287
1798
R05
ICD-10 Finland
Cough
1.4
12.0
691
5228
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.9
11.9
163
856
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.1
11.9
129
616
Z3229
NOMESCO Finland
Other healthcare associate professional
1.6
11.9
277
1724
A99
ICPC
Disease/condition unspecnature/site
1.7
11.9
270
1667
C09CA06
ATC
candesartan; oral
1.4
11.8
712
5423
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
8.4
11.8
25
30
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
11.7
495
3537
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.7
11.7
235
1400
C10AA01
ATC
simvastatin; oral
1.3
11.7
1192
9822
XF402
NOMESCO Finland
ECG with work load test
1.6
11.7
331
2165
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
11.7
380
2569
ZX120
NOMESCO Finland
Intravenous
1.6
11.6
293
1859
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.3
11.6
42
99
D05AX03
ATC
calcitriol; topical
5.7
11.6
32
56
N06AX16
ATC
venlafaxine; oral
1.4
11.6
544
3968
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.7
11.5
216
1261
R07.3
ICD-10 Finland
Other chest pain
1.6
11.5
300
1922
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
11.5
484
3455
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
11.5
253
1548
SPAT1260
SPAT
Consultation of another employee
1.4
11.5
633
4748
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
11.5
897
7115
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.6
11.5
333
2190
L03AX13
ATC
glatiramer acetate; parenteral
+∞
11.5
11
*
L04AA31
ATC
teriflunomide; oral
+∞
11.5
11
*
Z3226
NOMESCO Finland
Physiotherapist
1.4
11.5
639
4806
C01DA14
ATC
isosorbide mononitrate; oral
1.6
11.3
327
2150
ZXA10
NOMESCO Finland
Bilateral
1.4
11.3
638
4803
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.7
11.3
217
1278
X58
ICD-10 Finland
Exposure to other specified factors
1.5
11.3
464
3296
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.5
11.2
86
348
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.0
11.2
133
659
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
11.2
1463
12426
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
11.2
373
2535
SDA02
NOMESCO Finland
Parodonthologic therapy
1.3
11.2
1271
10609
D64.9
ICD-10 Finland
Anaemia, unspecified
1.6
11.2
263
1642
M03BX02
ATC
tizanidine; oral
1.2
11.2
2465
22230
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.4
11.1
90
376
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
11.1
506
3667
A01
ICPC
Pain general/multiple sites
1.6
11.1
261
1628
E27.2
ICD-10 Finland
Addisonian crisis
20.1
11.1
16
8
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
11.1
150
786
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
11.1
326
2153
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
11.1
283
1806
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
1.5
11.1
417
2910
N05BA04
ATC
oxazepam; oral
1.3
11.0
899
7169
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
11.0
364
2468
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.7
11.0
225
1348
CKC15
NOMESCO Finland
Panretinal photocoagulation
4.2
11.0
40
95
M54.6
ICD-10 Finland
Pain in thoracic spine
1.7
11.0
240
1467
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
11.0
274
1736
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
11.0
628
4739
D07AC01
ATC
betamethasone; topical
1.3
10.9
1168
9667
M01AE02
ATC
naproxen; oral, rectal
1.2
10.9
2282
20429
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
10.9
759
5910
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
10.9
1009
8190
K07.60
ICD-10 Finland
Snapping jaw
1.7
10.9
203
1183
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.0
10.9
137
696
E10.09
ICD-10 Finland
Insulin-dependent diabetes mellitus - With coma
15.5
10.8
17
11
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.3
10.8
790
6200
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
10.8
488
3531
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
10.7
1548
13285
A09AA02
ATC
multienzymes (lipase, protease etc.)
2.8
10.7
67
240
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
10.7
450
3209
R35
ICD-10 Finland
Polyuria
1.9
10.6
162
885
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
6.7
10.6
26
39
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.5
10.6
426
3012
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
10.5
834
6620
H3603, E113
ICD-10 Finland
NA
4.2
10.5
38
90
E10.01
ICD-10 Finland
Insulin-dependent diabetes diabetic coma with hyperglycemia
8.5
10.5
22
26
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.5
10.5
47
135
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
10.5
514
3777
E66.9
ICD-10 Finland
Obesity, unspecified
1.9
10.4
140
731
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
+∞
10.4
10
*
L04AA27
ATC
fingolimod; oral
+∞
10.4
10
*
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
10.4
446
3193
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
10.4
376
2602
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.8
10.3
161
886
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.8
10.3
183
1051
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
10.2
363
2500
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
10.2
170
958
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.5
10.2
79
321
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
4.5
10.2
35
79
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.9
10.2
136
708
L04AA13
ATC
leflunomide; oral
2.5
10.2
76
304
XCK00
NOMESCO Finland
Perimetry
1.7
10.2
207
1243
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.5
10.2
329
2223
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.2
10.2
95
428
N03AE01
ATC
clonazepam; systemic
1.8
10.1
184
1068
XF600
NOMESCO Finland
Bloodpressure measurement
1.7
10.1
196
1160
C08CA01
ATC
amlodipine; oral
1.3
10.1
993
8116
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.8
10.1
174
990
M48.0
ICD-10 Finland
Spinal stenosis
1.5
10.1
319
2143
H25.0
ICD-10 Finland
Senile incipient cataract
1.8
10.0
166
935
RJ210
NOMESCO Finland
NA
10.0
10.0
19
19
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.3
10.0
85
366
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
10.0
1155
9638
TFP20
NOMESCO Finland
Cardiodefibrillation
1.8
10.0
177
1021
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.5
9.9
301
2001
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
9.9
1057
8727
R03BA05
ATC
fluticasone; inhalant
1.3
9.9
676
5244
WX290
NOMESCO Finland
Other blockade of nerve
1.2
9.9
1758
15401
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.7
9.8
195
1160
E23.03
ICD-10 Finland
Lack of ACTH
12.2
9.8
17
14
L40.9
ICD-10 Finland
Psoriasis, unspecified
5.0
9.8
30
60
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.6
9.8
260
1672
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
9.8
277
1810
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
9.8
445
3218
M01AH01
ATC
celecoxib; oral (coxibs)
1.4
9.8
590
4489
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
9.7
429
3087
A12AA04
ATC
calcium carbonate; oral
3.1
9.7
50
160
N06AB03
ATC
fluoxetine; oral
1.4
9.7
470
3445
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
9.7
2051
18297
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
5.1
9.7
29
57
SPAT1216
SPAT
Assessment of functional ability
1.4
9.7
436
3151
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
2.7
9.7
65
245
C10AC01
ATC
colestyramine; oral
2.3
9.6
85
372
XKD00
NOMESCO Finland
Uroflowmetry
1.5
9.6
284
1878
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
9.6
682
5321
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
2.8
9.6
58
207
I49.1
ICD-10 Finland
Atrial premature depolarization
2.0
9.6
112
556
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
9.6
757
6000
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
8.4
9.5
20
24
T78.4
ICD-10 Finland
Allergy, unspecified
1.7
9.5
185
1097
L16
ICPC
Ankle symptom/complaint
1.5
9.5
365
2557
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
9.5
210
1289
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
9.5
172
997
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.2
9.5
89
401
O82.0
ICD-10 Finland
Delivery by elective caesarean section
1.7
9.4
181
1069
M35.7
ICD-10 Finland
Hypermobility syndrome
2.7
9.4
62
233
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.8
9.4
163
932
A06AD11
ATC
lactulose; oral
1.4
9.4
385
2731
L04AC10
ATC
secukinumab; parenteral
100.2
9.4
10
*
TFP46
NOMESCO Finland
Ablation treatment of atrial fibrillation
3.0
9.4
54
184
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
9.4
495
3682
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.5
9.4
69
276
H3602, E103
ICD-10 Finland
NA
7.5
9.4
21
28
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.4
9.4
408
2929
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.6
9.4
269
1765
M01AB05
ATC
diclofenac; systemic, rectal
1.2
9.4
2570
23502
SPAT1325
SPAT
Vaccination
1.3
9.3
1179
9932
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.3
9.3
86
386
WX002
NOMESCO Finland
Sedation and analgesia
1.3
9.3
626
4845
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
9.3
234
1491
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.7
9.2
198
1207
M35.3
ICD-10 Finland
Polymyalgia rheumatica
2.1
9.2
107
528
I20.09
ICD-10 Finland
Unstable angina
1.9
9.2
122
635
106
Kela drug reimbursment
Hypoparathyroidism
5.2
9.2
27
52
R02
ICPC
Shortness of breath/dyspnoea
1.4
9.2
393
2811
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.3
9.2
82
362
D07XC01
ATC
betamethasone, combinations; topical
1.5
9.1
311
2125
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.6
9.1
256
1674
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
1.9
9.1
132
711
J01CA08
ATC
pivmecillinam; oral
1.2
9.1
1790
15804
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.8
9.1
149
836
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
9.1
935
7671
CKC10
NOMESCO Finland
Local photocoagulation of retina
2.7
9.1
60
226
JN3AD
NOMESCO Finland
Abdominal CT examination
1.6
9.1
224
1416
B01AA03
ATC
warfarin; systemic
1.4
9.1
459
3388
XQ802
NOMESCO Finland
Epicutan test
1.8
9.1
154
873
R01AD12
ATC
fluticasone furoate; nasal
1.2
9.1
1184
10001
B05DB
ATC
Hypertonic solutions
6.2
9.1
23
37
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
9.0
755
6029
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.9
9.0
133
722
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.1
9.0
101
495
W84
ICPC
Pregnancy high risk
1.8
9.0
140
774
WZC30
NOMESCO Finland
Teaching
1.4
8.9
409
2967
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
8.9
1094
9175
R05
ICPC
Cough
1.3
8.9
804
6486
A11CC02
ATC
dihydrotachysterol; oral
6.1
8.9
23
38
P03
ICPC
Feeling depressed
1.5
8.9
356
2516
M01AH02
ATC
rofecoxib; oral
1.4
8.8
392
2825
R21
ICPC
Throat symptom/complaint
1.3
8.8
819
6633
E66.00
ICD-10 Finland
Metabolic syndrome
1.7
8.8
173
1027
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.5
8.8
67
272
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
1.9
8.8
117
614
M02AA07
ATC
piroxicam; topical
1.2
8.7
1244
10605
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.8
8.7
140
782
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.3
8.7
79
352
SPAT1254
SPAT
Administration of medicine
1.4
8.7
460
3422
R55
ICD-10 Finland
Syncope and collapse
1.5
8.7
300
2058
J02AC02
ATC
itraconazole; systemic
1.3
8.7
641
5027
J01FA01
ATC
erythromycin; systemic
1.3
8.7
560
4303
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
8.7
392
2836
SPAT1229
SPAT
Assessment of need for aid
1.6
8.7
226
1450
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.2
8.7
81
365
A01AB04
ATC
amphotericin B; local oral
1.8
8.6
152
873
J01EA01
ATC
trimethoprim; systemic
1.3
8.6
987
8204
R03BA08
ATC
ciclesonide; inhalant
1.5
8.6
283
1921
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.4
8.6
380
2737
T82
ICPC
Obesity
1.8
8.6
139
779
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
5.2
8.6
25
48
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.9
8.6
121
646
N03AX09
ATC
lamotrigine; oral
1.7
8.6
183
1117
N02AA05
ATC
oxycodone; systemic
1.4
8.6
386
2792
H03AA02
ATC
liothyronine sodium; systemic
11.6
8.6
15
13
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.2
8.6
83
381
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
16.3
8.5
13
8
N86
ICPC
Multiple sclerosis
16.3
8.5
13
8
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
8.5
739
5926
E05.4
ICD-10 Finland
Thyrotoxicosis factitia
9.0
8.5
17
19
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.5
8.5
65
265
R49.01
ICD-10 Finland
Functional dysphonia
1.9
8.5
114
597
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.6
8.4
222
1429
Z01.9
ICD-10 Finland
Special examination, unspecified
1.7
8.4
182
1114
S29
ICPC
Skin symptom/complaint other
1.3
8.4
548
4216
2554A
ICD-9 Finland
Disorders of adrenal glands, Corticoadrenal insufficiency[MORBUS ADDISON PRIMARIUS]
90.2
8.4
9
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.5
8.4
329
2316
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
8.4
370
2662
L15
ICPC
Knee symptom/complaint
1.3
8.4
711
5685
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.9
8.4
118
632
L04AA06
ATC
mycophenolic acid; systemic
2.8
8.4
50
178
L02
ICPC
Back symptom/complaint
1.5
8.3
324
2277
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.6
8.3
205
1296
D06
ICPC
Abdominal pain localized other
1.5
8.3
294
2024
M33.1
ICD-10 Finland
Other dermatomyositis
+∞
8.3
8
*
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
+∞
8.3
8
*
71312
ICD-8 Finland
Osteo-arthritis and allied conditions, Spondylarthritis lumbalis sive lumbosacralis
+∞
8.3
8
*
M07.2*L40.5
ICD-10 Finland
Psoriatic spondylitis
+∞
8.3
8
*
N06AX12
ATC
bupropion; oral
1.6
8.3
227
1475
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.5
8.3
247
1639
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.5
8.3
62
251
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.8
8.3
146
841
D82
ICPC
Teeth/gum disease
1.2
8.3
1346
11624
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.3
8.3
73
320
A10BA02
ATC
metformin; oral
1.3
8.3
757
6111
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.9
8.3
109
570
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.3
8.3
563
4360
Z2446
NOMESCO Finland
Social worker
1.6
8.3
214
1375
N05BA01
ATC
diazepam; systemic, rectal
1.4
8.2
435
3237
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.2
8.2
1123
9514
N03AF02
ATC
oxcarbazepine; oral
2.0
8.2
102
520
R01AD11
ATC
triamcinolone; nasal
1.5
8.2
312
2185
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
2.6
8.2
56
215
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.4
8.2
69
296
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
2.0
8.1
103
527
Z01.7
ICD-10 Finland
Laboratory examination
1.4
8.1
379
2758
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
8.1
419
3104
137
Kela drug reimbursment
Uraemia requiring dialysis
4.1
8.1
30
74
R03BA01
ATC
beclometasone; inhalant
1.4
8.1
480
3636
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
8.1
290
2002
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
1.9
8.1
111
586
R04
ICPC
Breathing problem other
1.9
8.1
105
545
L50.8
ICD-10 Finland
Other urticaria
2.2
8.1
75
339
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
33.4
8.1
10
*
-45
ICPC
Observ/health educat/advice/diet
1.9
8.1
111
589
K80
ICPC
Cardiac arrhythmia NOS
1.6
8.1
221
1440
R06AX13
ATC
loratadine; oral
1.3
8.0
588
4606
R74
ICPC
Upper respiratory infection acute
1.2
8.0
1162
9906
371
Kela drug reimbursment
Degludekinsuliini
8.9
8.0
16
18
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
8.0
639
5065
J01DA08
ATC
[U] cefaclor; oral
1.4
8.0
430
3210
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
8.0
1742
15480
ZXE10
NOMESCO Finland
More than one and less than three hours
1.2
8.0
1264
10882
0092A
ICD-9 Finland
Ill-defined intestinal infections, Infectious diarrhoea
3.2
8.0
39
122
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
5.5
8.0
22
40
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
7.9
226
1486
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.3
7.9
68
295
UJF92
NOMESCO Finland
Capsular endoscopy
2.5
7.9
58
231
Z71.8
ICD-10 Finland
Other specified counselling
1.3
7.9
901
7478
D11
ICPC
Diarrhoea
1.4
7.9
414
3073
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.6
7.9
194
1228
Z2445
NOMESCO Finland
Psychologist
1.7
7.9
149
877
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.8
7.9
127
711
H25.8
ICD-10 Finland
Other senile cataract
1.5
7.9
258
1751
N06AB06
ATC
sertraline; oral
1.4
7.9
403
2983
N06AG02
ATC
moclobemide; oral
1.7
7.9
152
901
R06AE09
ATC
levocetirizine; oral
1.3
7.9
555
4323
SPAT1255
SPAT
Intravenous administration of medicine
1.6
7.8
187
1176
ZY010
NOMESCO Finland
Hospital outpatient
1.6
7.8
182
1135
M35.1
ICD-10 Finland
Other overlap syndromes
6.1
7.8
20
33
A03
ICPC
Fever
1.3
7.8
604
4767
G63.2
ICD-10 Finland
Diabetic polyneuropathy
5.4
7.8
22
41
L04AD01
ATC
ciclosporin; systemic
2.6
7.8
52
199
RJ126
NOMESCO Finland
NA
8.4
7.8
16
19
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.3
7.8
65
280
D01
ICPC
Abdominal pain/cramps general
1.4
7.8
394
2909
-50
ICPC
Medication/prescr/renewal
1.8
7.8
132
753
AN1
HP
Coronary angiography
1.5
7.8
254
1724
J01MA14
ATC
moxifloxacin; systemic
1.5
7.8
258
1753
SPAT1312
SPAT
General health counselling
1.2
7.8
1224
10527
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
7.8
928
7741
F45.8
ICD-10 Finland
Other somatoform disorders
1.5
7.8
278
1921
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.5
7.7
231
1533
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
2.8
7.7
47
170
KMAK
NOMESCO Finland
NA
1.2
7.7
2058
18613
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.4
7.7
414
3086
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.6
7.7
173
1071
S21
ICPC
Skin texture symptom/complaint
1.4
7.7
389
2871
207
Kela drug reimbursment
Chronic arrhythmias
1.4
7.7
328
2347
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
2.4
7.7
61
256
N18.8
ICD-10 Finland
Other chronic renal failure
2.4
7.7
63
266
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.6
7.7
176
1097
TAB00
NOMESCO Finland
Lumbar puncture
1.7
7.7
138
802
SPAT1211
SPAT
Application of soft bandage
1.5
7.6
294
2064
ZXE20
NOMESCO Finland
More than three and less than five hours
1.4
7.6
401
2980
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.4
7.6
342
2474
A05
ICPC
Feeling ill
1.5
7.6
231
1540
UDC00
NOMESCO Finland
Ear microscopy
1.5
7.6
225
1494
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
7.6
325
2329
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
4.2
7.6
27
65
A46
ICD-10 Finland
Erysipelas
1.4
7.6
352
2560
TEA00
NOMESCO Finland
Biopsy of lip
3.4
7.6
34
100
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.2
7.6
1115
9518
E83.50
ICD-10 Finland
Hypercalcemia
2.8
7.6
46
167
N03AX11
ATC
topiramate; oral
1.9
7.5
101
532
Z50.1
ICD-10 Finland
Other physical therapy
1.7
7.5
163
1000
B05DA
ATC
Isotonic solutions
4.5
7.5
25
56
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.5
7.5
217
1432
L11
ICPC
Wrist symptom/complaint
1.5
7.5
287
2011
Z94.0
ICD-10 Finland
Kidney transplant status
3.3
7.5
36
111
S22
ICPC
Nail symptom/complaint
1.6
7.5
179
1125
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.0
7.5
85
419
XX9XE
NOMESCO Finland
Other ultrasound examination
3.4
7.5
34
101
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.8
7.5
44
156
G43.9
ICD-10 Finland
Migraine, unspecified
1.5
7.5
231
1550
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
2.1
7.4
83
408
SBB10
NOMESCO Finland
Teeth copy
1.5
7.4
238
1609
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
80.2
7.4
8
*
U05
ICPC
Urination problems other
1.8
7.4
123
697
E07.9
ICD-10 Finland
Disorder of thyroid, unspecified
5.0
7.4
22
44
R03AC03
ATC
terbutaline; inhalant
1.3
7.4
496
3835
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.0
7.4
93
478
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.5
7.4
218
1447
E20.8
ICD-10 Finland
Other hypoparathyroidism
13.4
7.4
12
9
L08
ICPC
Shoulder symptom/complaint
1.3
7.4
602
4784
S04
ICPC
Lump/swelling localized
1.4
7.3
308
2198
H93.1
ICD-10 Finland
Tinnitus
1.6
7.3
202
1316
N01
ICPC
Headache
1.4
7.3
416
3135
D05AX02
ATC
calcipotriol; topical
2.2
7.3
69
313
TFP35
NOMESCO Finland
Electroanatomical mapping
2.7
7.3
47
175
E000006
ATC
NA
1.5
7.3
232
1566
24502
ICD-8 Finland
Thyroiditis, Subchronica
+∞
7.3
7
*
M31.7
ICD-10 Finland
Microscopic polyangiitis
+∞
7.3
7
*
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
7.3
7
*
205
Kela drug reimbursment
Chronic hypertension
1.3
7.3
698
5663
R4190
NOMESCO Finland
Nutritional therapy
1.8
7.3
116
647
R51
ICD-10 Finland
Headache
1.6
7.3
192
1240
R39.1
ICD-10 Finland
Other difficulties with micturition
2.2
7.3
69
316
XG410
NOMESCO Finland
Flow-volume spirometry
1.8
7.3
127
731
A29
ICPC
General symptom/complaint other
1.4
7.2
338
2459
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
7.2
221
1478
H16.0
ICD-10 Finland
Corneal ulcer
1.7
7.2
138
818
Q90.9
ICD-10 Finland
Down syndrome, unspecified
15.8
7.2
11
7
0088X
ICD-9 Finland
Intestinal infections due to other organisms, Other organism, not elsewhere classified
3.1
7.2
36
115
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.3
7.2
800
6608
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.9
7.2
98
521
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.7
7.2
139
829
J01
ICD-10 Finland
Acute sinusitis
1.6
7.1
186
1196
25510
ICD-8 Finland
Diseases of adrenal glands, Adrenal cortical hypofunction
30.0
7.1
9
*
R94.6
ICD-10 Finland
Abnormal results of thyroid function studies
3.9
7.1
27
69
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
3.9
7.1
27
69
O24.1
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
3.6
7.1
30
84
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
2.9
7.1
41
142
WX892
NOMESCO Finland
Monitored bed care
1.5
7.1
206
1363
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
3.0
7.1
37
122
J35.0
ICD-10 Finland
Chronic tonsillitis
1.5
7.1
201
1319
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
1.4
7.1
310
2232
SFA00
NOMESCO Finland
Small filling
1.3
7.1
439
3354
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
3.2
7.1
34
106
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
7.1
285
2022
C05AA08
ATC
fluocortolone; rectal, topical
1.3
7.1
454
3485
T91
ICPC
Vitamin/nutritional deficiency
3.6
7.0
29
80
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
8.8
7.0
14
16
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.4
7.0
56
236
ZYC06
NOMESCO Finland
Real-time text-based remote transaction
7.0
7.0
16
23
NDE20
NOMESCO Finland
Suture or reinsertion of ligament of wrist or hand, open
7.0
7.0
16
23
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
2.8
7.0
42
152
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.5
7.0
206
1369
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.9
7.0
100
539
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.6
7.0
154
952
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.7
7.0
137
820
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.4
7.0
53
219
SBA00
NOMESCO Finland
Microbiological examinations
2.0
6.9
81
405
L03
ICPC
Low back symptom/complaint
1.2
6.9
859
7188
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
5.1
6.9
20
39
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.4
6.9
368
2743
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.5
6.9
52
212
81
HP
Angiography of the heart and coronary arteries
1.8
6.9
122
704
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.8
6.9
111
622
M01AC06
ATC
meloxicam; systemic, rectal
1.2
6.9
1277
11135
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
5.8
6.9
18
31
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
6.9
233
1595
C09CA01
ATC
losartan; oral
1.3
6.9
684
5576
D05BB02
ATC
acitretin; oral
2.9
6.9
38
131
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.4
6.8
268
1887
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
3.9
6.8
26
67
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.9
6.8
97
522
L50.3
ICD-10 Finland
Dermatographic urticaria
2.2
6.8
64
293
R03AK08
ATC
formoterol and beclometasone; inhalant
1.8
6.8
118
679
J01FA15
ATC
telithromycin; oral
1.4
6.8
344
2539
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.0
6.8
82
414
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.5
6.8
255
1783
N05BA12
ATC
alprazolam; oral
1.4
6.8
336
2474
R03BA02
ATC
budesonide; inhalant
1.3
6.8
628
5073
D94
ICPC
Chronic enteritis/ulcerative colitis
6.7
6.8
16
24
J45
ICD-10 Finland
Asthma
1.4
6.8
329
2411
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
1.9
6.8
93
496
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.7
6.8
142
864
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
2.0
6.8
82
416
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
5.0
6.8
20
40
D02
ICPC
Abdominal pain epigastric
1.5
6.8
196
1297
M54.3
ICD-10 Finland
Sciatica
1.6
6.8
185
1205
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.3
6.8
434
3333
F49
ICPC
Eye, Other preventive procedure
16.7
6.7
10
6
A41.9
ICD-10 Finland
Sepsis, unspecified
1.9
6.7
86
447
E000003
ATC
NA
1.7
6.7
141
858
127
Kela drug reimbursment
Transplant complication
2.6
6.7
45
175
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.2
6.7
67
314
H3601, E113
ICD-10 Finland
NA
2.8
6.7
40
145
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
3.6
6.7
28
79
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.2
6.7
919
7776
D09
ICPC
Nausea
1.6
6.6
160
1010
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.7
6.6
137
830
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.4
6.6
257
1810
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.1
6.6
72
351
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
6.4
6.6
16
25
TK820
NOMESCO Finland
Peritoneal dialysis
6.4
6.6
16
25
SPAT1104
SPAT
Monitoring of emergency patient
1.5
6.6
197
1309
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
1.9
6.6
91
484
J37.0
ICD-10 Finland
Chronic laryngitis
1.8
6.6
101
559
ZXA00
NOMESCO Finland
Right side
1.2
6.6
841
7055
E05.5
ICD-10 Finland
Thyroid crisis or storm
12.2
6.6
11
9
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
6.5
575
4616
T99
ICPC
Endocr/metab/nutrit disease other
2.4
6.5
53
226
N18.0
ICD-10 Finland
End-stage renal disease
3.3
6.5
30
91
R51.81
ICD-10 Finland
Facial pain NOS
2.0
6.5
82
422
A02BA04
ATC
nizatidine; systemic
1.5
6.5
214
1457
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
4.8
6.5
20
42
L12
ICPC
Hand/finger symptom/complaint
1.3
6.5
486
3813
TFC25
NOMESCO Finland
Transseptal catheterisation of left atrium or ventricle
2.7
6.5
42
157
D02AX
ATC
Other emollients and protectives
1.7
6.5
115
668
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
6.5
913
7739
L04
ICPC
Chest symptom/complaint
1.5
6.4
177
1159
H26.2
ICD-10 Finland
Complicated cataract
2.7
6.4
40
149
L60.0
ICD-10 Finland
Ingrowing nail
1.7
6.4
132
802
M46.3
ICD-10 Finland
Infection of intervertebral disc (pyogenic)
69.9
6.4
7
*
CAC44
NOMESCO Finland
Combined decompression of orbit
69.9
6.4
7
*
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.3
6.4
451
3507
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.6
6.4
164
1052
H01
ICPC
Ear pain/earache
1.3
6.4
386
2934
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
3.2
6.4
31
98
D07AA02
ATC
hydrocortisone; topical
1.3
6.4
473
3709
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
6.4
1588
14205
U02
ICPC
Urinary frequency/urgency
1.3
6.4
464
3627
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
4.1
6.4
23
57
SPAT1240
SPAT
Therapeutic discussion
1.3
6.4
402
3080
J03.0
ICD-10 Finland
Streptococcal tonsillitis
1.7
6.4
112
650
N06AX26
ATC
vortioxetine; oral
1.5
6.4
194
1297
R31
ICD-10 Finland
Unspecified haematuria
1.5
6.4
209
1424
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
1.9
6.3
89
479
25008
ICD-8 Finland
Diabetes mellitus, Complicatio alia definita
8.1
6.3
13
16
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.1
6.3
67
322
J20
ICD-10 Finland
Acute bronchitis
1.4
6.3
310
2278
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.5
6.3
217
1490
K59.0
ICD-10 Finland
Constipation
1.6
6.3
160
1028
WZA00
NOMESCO Finland
Short statement of of health and health related matters
1.5
6.3
204
1386
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.4
6.3
51
216
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
5.9
6.3
16
27
C08DA01
ATC
verapamil; systemic
1.7
6.3
120
712
XCK20
NOMESCO Finland
NA
5.5
6.3
17
31
K04
ICPC
Palpitations/awareness of heart
1.6
6.3
166
1077
C07AA07
ATC
sotalol; systemic
1.8
6.3
93
512
K74.3
ICD-10 Finland
Primary biliary cirrhosis
3.6
6.3
26
73
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.6
6.3
167
1083
R03DA04
ATC
theophylline; systemic, rectal
1.7
6.3
127
770
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
6.2
6
*
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
6.2
6
*
71310
ICD-8 Finland
Osteo-arthritis and allied conditions, Spondylarthritis cervicalis
+∞
6.2
6
*
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
6.2
6
*
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
+∞
6.2
6
*
M06.1
ICD-10 Finland
Adult-onset Still disease
+∞
6.2
6
*
ACC51
NOMESCO Finland
Release of median nerve
1.4
6.2
242
1703
CAC30
NOMESCO Finland
Decompression of orbit to sinuses
26.7
6.2
8
*
H3600, E109
ICD-10 Finland
NA
26.7
6.2
8
*
B02AA02
ATC
tranexamic acid; systemic
1.3
6.2
576
4650
F34.1
ICD-10 Finland
Dysthymia
1.7
6.2
121
722
BA1AE
SPAT
NA
2.8
6.2
37
134
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
1.9
6.2
78
405
G50.1
ICD-10 Finland
Atypical facial pain
2.1
6.2
64
306
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.5
6.2
177
1167
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
2.6
6.2
42
165
E87.6
ICD-10 Finland
Hypokalaemia
1.9
6.2
88
478
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
2.3
6.2
51
221
C07AB03
ATC
atenolol; systemic
1.6
6.2
147
927
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.4
6.2
313
2314
L29
ICPC
Musculoskeletal sympt/complt other
1.4
6.2
238
1675
R06.2
ICD-10 Finland
Wheezing
1.6
6.1
142
888
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
1.6
6.1
155
994
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
1.8
6.1
97
545
S08
ICPC
Skin colour change
1.6
6.1
140
874
L18
ICPC
Muscle pain
1.7
6.1
118
703
E14.0
ICD-10 Finland
Unspecified diabetes mellitus, with coma
12.5
6.1
10
8
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.8
6.1
89
488
5790A
ICD-9 Finland
Intestinal malabsorption, Coeliac disease
8.6
6.0
12
14
S22.3
ICD-10 Finland
Fracture of rib
1.6
6.0
157
1014
RJ420
NOMESCO Finland
NA
4.9
6.0
18
37
R03BB04
ATC
tiotropium bromide; inhalant
1.5
6.0
225
1572
SPAT1054
SPAT
Examination of peripheral nervous system
2.3
6.0
53
237
R05FB02
ATC
cough suppressants and expectorants
1.2
6.0
1296
11434

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1475
2931
6.72
307.65
4.2
3.2
pmol/l
4.5
4.5
0.81
1333
2625
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
1309
3474
4.75
307.65
1.5
1.2
iu/ml
269.6
148.1
14.25
732
1285
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
682
1134
6.81
307.65
2.0
1.9
iu/l
3.7
4.6
1.16
270
412
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
4646
34141
6.19
290.59
10.5
4.1
pmol/l
15.6
14.6
112.35
4466
31415
(3036481) Cortisol [Moles/volume] in Serum or Plasma
990
3753
3.04
190.57
2.5
2.1
nmol/l
370.4
382.2
1.09
916
3448
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4736
39427
4.91
159.26
11.9
4.8
mu/l
2.0
2.0
0.02
4542
36606
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2794
18647
2.13
144.81
7.9
6.0
mmol/l
1.2
1.2
0.33
2354
15707
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2601
17065
2.09
138.96
2.8
2.1
nmol/l
77.1
76.4
0.59
2412
15462
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1736
10305
2.05
116.25
1.5
1.3
u/ml
1.4
1.6
0.32
476
2848
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2492
16865
1.95
113.70
7.1
5.4
mmol/l
1.2
1.2
0.48
2268
15236
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3801
30045
2.11
107.36
8.4
6.5
u/l
78.6
76.7
1.01
3615
28139
(3013826) Glucose [Moles/volume] in Serum or Plasma
3062
22477
1.94
106.68
5.6
4.2
mmol/l
7.0
6.5
20.70
2874
20674
(3013115) Eosinophils [#/volume] in Blood
2813
20112
1.91
105.82
7.0
5.0
e9/l
0.2
0.2
0.53
2528
17609
(3013707) Erythrocyte sedimentation rate by Westergren method
3806
30163
2.10
105.79
5.3
3.5
mm/h
12.4
11.2
6.20
3582
27968
(3006315) Basophils [#/volume] in Blood
2724
19355
1.90
103.55
6.7
4.8
e9/l
0.0
0.0
1.03
2425
16588
(3020682) Albumin/Creatinine [Ratio] in Urine
1704
10433
1.96
101.52
5.3
3.9
mg/mmol
9.2
9.0
0.04
1159
6376
(3001604) Monocytes [#/volume] in Blood
2706
19281
1.88
100.95
6.7
4.8
e9/l
0.6
0.6
1.45
2410
16548
(3019198) Lymphocytes [#/volume] in Blood
2780
20003
1.88
100.30
6.8
4.8
e9/l
1.9
2.0
0.45
2532
17577
(3013650) Neutrophils [#/volume] in Blood by Automated count
3056
22695
1.89
99.50
9.2
8.2
e9/l
4.0
4.0
0.02
2728
19656
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
129
156
8.46
98.96
1.6
1.6
pmol/l
15.9
14.4
0.59
114
128
(3037522) Nuclear Ab [Titer] in Serum
1044
5418
2.17
97.26
1.5
1.3
titre
537.9
492.8
0.33
286
1006
(3007164) IgA [Mass/volume] in Serum or Plasma
1462
8595
1.99
97.19
1.6
1.4
g/l
2.1
2.2
1.42
866
5127
(3022096) Basophils/100 leukocytes in Blood
2494
17490
1.85
96.08
7.0
4.9
%
0.7
0.7
0.81
2319
16203
(3002030) Lymphocytes/100 leukocytes in Blood
2648
18939
1.85
95.53
7.1
4.9
%
29.4
29.1
0.75
2462
17568
(3019069) Monocytes/100 leukocytes in Blood
2573
18248
1.85
95.31
7.3
5.2
%
8.4
8.2
2.90
2412
17006
(3018010) Neutrophils/100 leukocytes in Blood
2608
18654
1.83
93.17
6.8
4.8
%
56.0
56.5
1.57
2434
17364
(3006504) Eosinophils/100 leukocytes in Blood
2551
18138
1.83
92.79
7.0
4.9
%
2.9
2.8
0.31
2374
16772
(3024561) Albumin [Mass/volume] in Serum or Plasma
2281
15683
1.84
92.51
5.0
4.2
g/l
36.0
36.0
0.37
2117
14498
(3012516) Albumin [Mass/volume] in Urine
1607
9949
1.91
90.41
4.4
3.2
mg/l
156.1
376.0
2.30
1051
6042
(3009508) Creatinine [Moles/volume] in Urine
1754
11228
1.87
88.52
4.4
3.1
mmol/l
7.2
7.3
0.23
1541
9514
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2695
19689
1.80
87.60
3.7
2.8
ug/l
97.0
94.3
0.30
2500
18390
(42870588) Differential panel, method unspecified - Blood
1899
12496
1.84
87.46
7.0
4.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1689
10815
1.85
84.22
2.3
2.0
u/l
130.8
191.6
3.94
1592
10158
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1531
9528
1.88
83.43
2.5
2.1
mg/l
2.8
2.9
1.12
1327
8099
(3018418) pH of Serum or Plasma
1687
10966
1.81
78.96
4.8
3.7
ph
7.4
7.4
0.94
317
2092
(3019550) Sodium [Moles/volume] in Serum or Plasma
4683
41893
2.90
75.97
18.6
13.1
mmol/l
139.4
139.7
11.86
4596
40737
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2162
15273
1.73
74.74
2.2
1.9
pmol/l
99.8
98.0
0.81
1153
7588
(3023103) Potassium [Moles/volume] in Serum or Plasma
4685
42026
2.86
73.55
18.8
13.2
mmol/l
3.9
3.9
3.11
4592
40767
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2633
19843
1.69
70.05
6.0
5.9
umol/l
10.3
10.5
0.30
2505
18687
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
596
2788
2.29
69.91
3.8
3.5
ng/l
83.0
79.9
0.41
519
2396
(3005719) IgG [Mass/volume] in Serum or Plasma
563
2600
2.31
67.98
2.8
2.6
g/l
10.7
10.3
1.67
513
2375
(3022948) Iron [Moles/volume] in Serum or Plasma
982
5616
1.93
67.28
2.9
2.3
umol/l
13.6
13.6
0.14
899
5185
(3015377) Calcium [Moles/volume] in Serum or Plasma
1901
13315
1.69
65.23
3.1
3.3
mmol/l
2.3
2.4
4.77
1660
11700
(3035637) Corticotropin [Mass/volume] in Plasma
187
495
3.89
61.79
2.0
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
895
5096
1.92
61.58
2.8
2.3
g/l
2.4
2.4
0.05
821
4699
(3003458) Phosphate [Moles/volume] in Serum or Plasma
822
4560
1.96
61.06
6.5
5.3
mmol/l
1.1
1.0
0.43
773
4226
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4203
36690
1.92
60.47
7.4
5.0
mmol/mol
42.0
38.8
54.12
3965
34144
(3032080) INR in Blood by Coagulation assay
1930
13824
1.65
59.15
7.7
7.6
inr
1.2
1.2
0.74
554
4106
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
824
4660
1.92
57.51
2.9
2.4
%
23.3
23.1
0.16
681
3998
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1188
7521
1.76
57.47
1.4
1.3
iu/ml
28.1
28.5
0.04
344
2322
(3037467) Urinalysis macro (dipstick) panel - Urine
3412
28259
1.66
56.83
5.4
4.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
290
1070
2.82
55.80
2.2
1.3
g/l
0.2
0.2
3.62
281
1007
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1867
13409
1.63
55.69
3.9
3.2
ng/l
30.2
41.8
1.21
1133
7928
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1705
11975
1.64
55.62
3.2
2.4
u/l
54.7
57.4
1.73
1580
11009
(3015171) Extractable nuclear Ab [Units/volume] in Serum
369
1545
2.50
55.10
1.3
1.2
u/ml
1.2
0.9
0.18
45
138
(36660697) Celiac disease serology panel - Serum
683
3674
2.00
55.03
1.2
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
295
1107
2.77
54.96
2.2
1.3
g/l
1.2
1.2
0.90
286
1044
(3028026) IgM [Mass/volume] in Serum or Plasma
442
2012
2.31
54.76
1.9
1.7
g/l
1.3
1.4
0.92
401
1835
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4599
41813
2.27
53.83
17.1
11.5
mg/l
19.0
21.8
7.92
3844
32281
(3012095) Magnesium [Moles/volume] in Serum or Plasma
961
5826
1.80
53.41
3.4
3.3
mmol/l
0.8
0.8
0.36
890
5424
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1346
8989
1.68
52.90
3.1
2.9
ng/l
1198.1
1140.5
0.16
1128
7588
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1123
7140
1.74
52.89
1.4
1.3
u/ml
11.6
10.9
0.12
462
2858
(3048689) Calprotectin [Mass/mass] in Stool
828
4811
1.86
52.77
2.2
1.3
ug/g
111.5
85.5
1.38
631
3584
(3019309) Folate [Moles/volume] in Red Blood Cells
1020
6346
1.76
51.71
1.8
1.7
nmol/l
1158.4
1181.0
0.33
820
4820
(3031040) Bacteria [#/volume] in Urine by Automated count
3280
27447
1.57
47.13
5.3
4.2
e6/l
1811.0
1758.9
0.02
61
320
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
283
1132
2.59
46.38
2.0
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1197
8006
1.65
45.67
1.7
1.6
pmol/l
36583430.2
34586122.6
0.04
995
6734
(3035350) Ketones [Presence] in Urine by Test strip
2523
20029
1.52
45.35
4.2
3.4
estimate
0.0
0.0
1.08
448
3591
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1779
13112
1.55
44.93
3.5
3.0
u/l
30.7
31.7
0.38
1704
12467
(3009261) Glucose [Presence] in Urine by Test strip
2547
20300
1.52
44.66
4.3
3.4
estimate
0.0
0.0
1.55
441
3613
(3026782) Osmolality of Urine
1076
7103
1.66
42.83
3.0
2.5
mosm/kgh2o
519.3
533.7
1.10
914
6016
(3018095) Leukocytes [#/volume] in Urine
1814
13537
1.53
42.74
4.2
3.3
e6/l
95.2
99.7
0.05
1321
9071
(3021601) Nitrite [Presence] in Urine by Test strip
2516
20137
1.50
42.31
5.9
4.6
estimate
0.0
0.0
0.34
453
3659
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
213
780
2.81
41.49
1.7
1.5
iu/ml
69.0
0.4
0.49
48
167
(3023368) Bacteria identified in Blood by Culture
1279
8880
1.59
41.21
4.4
4.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4271
38535
1.75
41.21
15.1
10.6
ml/min/173m2
84.6
84.8
0.21
3639
31295
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
261
1080
2.49
39.80
1.3
1.2
u/ml
15.8
24.9
0.31
17
48
(40760892) CBC W Ordered Manual Differential panel - Blood
1282
8974
1.58
39.62
4.4
3.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1124
7633
1.61
39.49
2.8
2.3
e6/l
6.9
7.4
0.42
994
6617
(3002582) Erythrocytes [#/volume] in Urine
1523
11106
1.53
39.10
3.5
2.9
e6/l
43.9
79.6
1.53
1220
8264
(3030313) Adrenal Ab [Titer] in Serum
43
42
10.32
38.65
1.2
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1198
8303
1.58
38.47
1.7
1.5
nmol/l
20.1
21.0
1.43
1041
7102
(3021589) Normoblasts [#/volume] in Blood
2228
17618
1.48
38.36
10.5
8.0
e9/l
0.0
0.0
0.39
1853
14226
(3009445) Proteinase 3 Ab [Units/volume] in Serum
296
1318
2.32
38.34
1.5
1.1
u/ml
5.4
2.8
—
10
5
(3013512) EKG study
1449
10507
1.53
37.94
4.1
3.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
146
454
3.28
37.84
2.3
4.8
u/ml
177.4
70.9
0.92
58
132
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
624
3662
1.80
37.58
4.0
4.2
u/l
229.8
243.4
1.79
595
3457
(3012544) pH of Venous blood
547
3102
1.86
36.79
4.6
3.8
ph
7.4
7.4
—
5
15
(3002032) Base excess in Venous blood by calculation
533
3004
1.87
36.54
4.6
3.9
mmol/l
2.0
1.9
0.25
445
2449
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4718
44232
2.21
36.52
12.7
8.8
u/l
25.2
24.8
0.59
4596
42678
(3021447) Carbon dioxide [Partial pressure] in Venous blood
533
3020
1.86
35.90
4.7
3.9
kpa
5.9
5.8
0.42
520
2927
(3011985) Renin [Units/volume] in Plasma
146
473
3.15
35.38
3.4
1.4
mu/l
136.2
48.1
2.13
130
424
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
119
344
3.52
34.61
1.9
2.4
nmol/l
19.5
20.4
0.40
114
330
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1429
10496
1.51
34.58
1.8
1.6
mmol/l
1.4
1.4
0.05
1216
8915
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
325
1571
2.14
34.42
2.1
2.0
u/l
39.6
39.9
0.08
303
1421
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
208
832
2.57
34.05
1.3
1.2
u/ml
37.5
35.2
0.07
26
72
(3024980) IgG subclass 4 [Mass/volume] in Serum
159
556
2.92
33.74
1.6
1.5
g/l
0.6
0.8
0.95
121
417
(3004588) Protein electrophoresis panel - Serum or Plasma
390
2032
2.00
33.72
2.2
2.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
459
2536
1.89
33.37
2.4
2.6
g/l
67.7
66.6
2.98
425
2312
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
429
2320
1.93
33.28
1.7
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
227
958
2.43
33.15
1.3
1.2
u/ml
7.1
2.7
0.56
29
62
(3026008) Bacteria identified in Urine by Culture
1628
12366
1.47
32.99
3.3
2.9
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
304
1462
2.15
32.60
3.7
3.2
mmol/l
25.4
25.3
0.15
295
1413
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1265
9155
1.51
32.50
1.9
1.7
mg/l
1.0
1.0
0.09
936
6869
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
843
5576
1.62
32.26
1.9
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
764
4936
1.65
32.13
1.7
1.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
227
972
2.40
32.11
1.3
1.2
u/ml
9.3
10.0
0.06
37
132
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
242
1067
2.33
32.03
1.7
1.4
titre
267.1
346.7
0.20
14
30
(3030467) Casts [#/volume] in Urine by Automated count
1379
10221
1.48
31.31
3.3
2.8
e6/l
0.5
0.4
0.24
1078
7498
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1962
15555
1.43
31.17
4.4
3.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
447
2512
1.86
30.74
3.7
3.3
kpa
4.5
4.6
0.76
434
2430
(3027945) Reticulocytes/100 erythrocytes in Blood
581
3564
1.71
29.60
2.7
2.6
%
1.7
1.8
0.80
512
3172
(3001019) Free T4 and TSH panel - Serum or Plasma
494
2898
1.78
29.46
2.5
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
1334
9930
1.47
29.27
7.1
6.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
806
5404
1.59
28.85
1.2
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
482
2832
1.78
28.56
8.8
7.0
mmol/l
9.1
8.6
0.88
460
2719
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
222
992
2.30
28.49
2.2
2.1
mg/l
10.8
11.1
0.16
210
921
(3023420) DNA double strand Ab [Units/volume] in Serum
113
358
3.21
28.47
2.2
1.2
iu/ml
37.3
25.9
—
9
11
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
186
771
2.47
28.26
1.3
1.2
u/ml
1.2
3.7
0.68
19
39
(36304419) Bacteria [Presence] in Urine
1345
10095
1.45
28.05
3.3
2.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
4663
44087
1.87
26.65
16.1
11.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
344
1862
1.91
26.49
1.2
1.1
u/ml
9.7
2.0
—
6
20
(3028192) IgG subclass 2 [Mass/volume] in Serum
111
364
3.10
26.42
1.5
1.3
g/l
2.8
2.8
0.07
78
257
(3024139) IgG subclass 3 [Mass/volume] in Serum
111
364
3.10
26.42
1.5
1.3
g/l
0.4
0.4
0.53
77
255
(3027135) IgG subclass 1 [Mass/volume] in Serum
111
365
3.09
26.30
1.5
1.3
g/l
7.0
6.6
0.47
77
257
(3019225) pH of Specimen
586
3714
1.65
26.24
5.3
3.9
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
151
591
2.60
25.89
4.8
6.0
iu/ml
278.9
351.9
0.27
18
77
(3002179) Metamyelocytes/100 leukocytes in Blood
442
2605
1.76
25.83
3.9
3.5
%
0.6
0.6
0.24
95
524
(3030981) Hyaline casts [#/volume] in Urine by Automated count
317
1684
1.94
25.82
3.2
2.5
e6/l
0.2
0.3
1.72
307
1620
(3004119) Hemoglobin [Mass/volume] in Venous blood
349
1927
1.87
25.27
3.6
3.2
g/l
130.7
128.8
1.01
343
1879
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
966
6925
1.49
25.06
2.9
2.8
mmol/l
2.4
2.4
3.86
823
6033
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4421
41301
1.61
25.02
5.7
4.4
mmol/l
2.8
2.9
4.89
4148
38308
(3000991) Gas panel - Venous blood
461
2782
1.72
24.76
9.4
8.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1252
9452
1.43
24.75
2.7
2.4
umol/l
3107.1
4246.6
0.61
1085
8245
(3017181) Myelocytes/100 leukocytes in Blood
470
2859
1.71
24.51
4.2
3.7
%
0.8
1.0
0.57
133
731
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4368
40731
1.58
24.44
5.1
4.0
mmol/l
4.7
4.8
6.47
4109
38047
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
177
768
2.35
24.33
1.3
1.2
u/ml
13.1
6.9
—
5
8
(4062490)
108
366
2.99
24.31
1.6
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4345
40490
1.56
24.13
5.1
4.0
mmol/l
1.5
1.5
1.43
4073
37644
(3014576) Chloride [Moles/volume] in Serum or Plasma
623
4093
1.60
24.00
7.8
6.7
mmol/l
104.3
104.5
0.67
610
4008
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4207
38951
1.51
23.88
4.6
3.6
mmol/l
1.3
1.2
0.57
3926
36027
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
186
833
2.28
23.77
2.0
1.2
iu/ml
10.9
8.6
—
7
10
(3018677) aPTT in Platelet poor plasma by Coagulation assay
770
5333
1.52
23.43
2.2
2.1
s
29.4
29.4
0.15
746
5173
(3022217) INR in Platelet poor plasma by Coagulation assay
621
4108
1.58
23.19
23.6
20.9
inr
1.2
1.3
1.36
108
607
(3007853) Bacteria identified in Skin by Aerobe culture
662
4456
1.56
22.90
1.9
1.7
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
72
197
3.69
22.83
1.4
1.3
u/l
4.7
5.9
0.79
55
168
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
254
1308
1.99
22.63
1.1
1.1
u/ml
6.1
5.7
0.03
30
186
(3009214) Lutropin [Units/volume] in Serum or Plasma
261
1357
1.97
22.62
1.5
1.4
u/l
13.3
11.5
0.85
210
1106
(3023520) Reticulocytes [#/volume] in Blood
431
2617
1.71
22.58
2.7
2.6
e9/l
69.9
70.8
0.21
329
1935
(3029937) Albumin [Presence] in Urine by Test strip
1362
10575
1.40
22.57
4.5
3.7
estimate
0.0
0.0
1.70
447
3597
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
278
1481
1.93
22.44
2.1
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
933
6775
1.46
22.40
4.1
3.3
ng/l
320.9
374.2
0.19
613
4689
(3007566) Smooth muscle Ab [Titer] in Serum
200
949
2.15
22.20
1.2
1.2
titre
98.0
174.5
0.58
15
85
(3000494) Fungus identified in Specimen by Culture
650
4407
1.55
21.70
1.6
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
258
1358
1.95
21.58
2.0
1.8
g/l
1.4
1.5
0.89
215
1169
(3021387) Prolactin [Units/volume] in Serum or Plasma
345
1994
1.78
21.49
2.0
1.6
mu/l
315.4
314.8
0.01
313
1785
(3041096) Erythrocytes [Presence] in Urine by Automated
1414
11122
1.38
21.46
4.0
3.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
359
2101
1.76
21.43
4.1
3.5
kpa
5.2
5.2
0.14
331
1967
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
166
743
2.28
21.27
2.8
2.4
ug/min
59.6
98.2
1.01
118
438
(3044889) 12 lead EKG panel
3095
27398
1.34
21.22
4.0
3.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
132
534
2.51
21.19
1.3
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
199
960
2.12
21.17
1.3
1.2
titre
1012.9
751.1
—
7
38
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
268
1440
1.91
21.08
3.1
2.9
%
0.7
0.6
0.49
261
1380
(3021440) Promyelocytes/100 leukocytes in Blood
438
2729
1.66
20.78
4.3
3.7
%
0.1
0.2
0.90
123
668
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
518
3368
1.60
20.71
2.6
2.1
g/l
0.2
0.2
0.02
489
3157
(3020961) Endomysium IgA Ab [Titer] in Serum
372
2221
1.73
20.69
1.2
1.1
titre
133.9
172.5
0.28
14
65
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
345
2017
1.76
20.66
4.0
3.5
mmol/l
1.5
1.7
0.37
264
1498
(3019150) Specific gravity of Urine by Refractometry
1141
8707
1.40
20.63
4.4
3.7
kg/l
1.0
1.0
0.87
198
1344
(3009343) pH of Capillary blood
353
2079
1.75
20.60
4.0
3.5
ph
7.4
7.4
0.15
41
249
(3044640) Blood type and Crossmatch panel - Blood
1610
12997
1.35
20.51
2.5
2.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
852
6178
1.46
20.42
2.9
2.4
e6/l
1.2
1.3
0.29
502
3345
(3039162) Centromere protein B Ab [Units/volume] in Serum
120
474
2.57
20.26
1.3
1.2
u/ml
61.3
60.3
0.02
15
32
(3021879) Hepatitis B virus core Ab [Presence] in Serum
489
3157
1.61
20.11
1.5
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
262
1422
1.89
19.99
1.3
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
124
502
2.51
19.90
2.9
3.0
u/ml
213.3
1511.9
—
8
30
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1237
9627
1.38
19.74
1.8
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1203
9321
1.38
19.73
3.9
3.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
213
1083
2.01
19.68
2.4
2.4
g/l
10.2
10.1
0.15
185
915
(3007461) Platelets [#/volume] in Blood
4861
47040
2.26
19.68
26.0
17.3
e9/l
264.2
260.3
4.18
4786
45875
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
250
1346
1.90
19.55
2.1
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
115
453
2.57
19.54
1.4
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
561
3766
1.55
19.48
1.4
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
414
2587
1.65
19.40
4.2
3.7
%
0.0
0.2
0.58
106
566
(3024731) MCV [Entitic volume]
4861
47071
2.24
19.12
25.9
17.2
fl
90.4
90.5
1.37
4820
46444
(3035941) MCH [Entitic mass]
4861
47073
2.24
19.08
25.8
17.2
pg
30.0
30.1
3.11
4820
46444
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1028
7798
1.40
19.04
1.8
1.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
4861
47080
2.23
18.96
26.0
17.3
e12/l
4.5
4.5
0.17
4785
45800
(3000963) Hemoglobin [Mass/volume] in Blood
4861
47093
2.22
18.72
26.1
17.4
g/l
133.5
134.0
1.99
4821
46465
(3010813) Leukocytes [#/volume] in Blood
4860
47087
2.21
18.59
26.0
17.3
e9/l
6.7
6.7
0.04
4785
45795
(3042936) Bacteria identified in Isolate by Culture
710
5064
1.47
18.38
2.2
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
221
1167
1.94
18.33
2.4
2.3
g/l
3.6
3.7
0.88
165
834
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
221
1168
1.93
18.28
2.4
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
221
1169
1.93
18.24
2.4
2.3
g/l
7.4
7.4
0.11
169
884
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4230
39661
1.44
18.13
4.9
4.1
mmol/l
6.1
5.8
23.33
3944
36485
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1243
9824
1.35
17.66
2.5
2.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
118
495
2.42
17.58
1.4
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
459
3026
1.57
17.20
3.7
3.5
mmol/l
1.2
1.2
0.37
393
2616
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
417
2694
1.60
17.04
1.3
1.3
au/ml
28.7
48.0
1.09
13
128
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
780
5768
1.42
16.49
3.1
2.6
e6/l
3.8
3.7
0.12
433
2953
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
445
2942
1.56
16.45
2.5
2.4
au/ml
21.7
23.9
0.16
24
196
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
91
349
2.64
16.38
1.2
1.2
u/l
55.7
58.7
0.23
63
237
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
143
672
2.16
16.34
1.6
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1229
9796
1.34
16.29
4.5
3.5
%
95.3
94.0
1.02
1191
9535
(1761482) Bacteria [#/volume] in Urine by Culture
166
831
2.03
16.07
5.0
4.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3122
28171
1.29
15.96
3.6
2.9
u/l
45.1
40.7
1.43
2945
26452
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
231
1298
1.82
15.82
1.5
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
434
2881
1.55
15.75
8.2
6.7
mmol/l
1.3
1.3
0.08
416
2776
(3016502) Oxygen saturation in Arterial blood
475
3220
1.53
15.66
8.9
7.5
%
95.7
96.0
0.46
462
3094
(3034860) Kappa light chains.free [Mass/volume] in Serum
176
908
1.97
15.66
3.0
3.4
mg/l
49.9
116.1
0.54
140
746
(3005322) IgE [Units/volume] in Serum or Plasma
437
2911
1.55
15.61
1.4
1.3
u/ml
118.5
191.8
2.91
402
2684
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
152
745
2.07
15.59
2.8
2.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
270
1598
1.73
15.48
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
401
2625
1.57
15.47
2.8
2.8
ng/l
175.4
159.5
0.39
365
2377
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
203
1105
1.87
15.39
2.4
2.4
g/l
3.0
3.1
0.86
168
859
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
175
908
1.96
15.33
3.0
3.4
mg/l
26.6
49.7
1.83
140
745
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
403
2648
1.57
15.29
2.5
2.2
ug/l
5.7
6.1
0.14
357
2309
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
152
753
2.05
15.16
1.4
1.2
u/ml
322.9
258.8
1.06
106
463
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
170
879
1.97
15.04
3.0
3.3
ratio
1.3
1.5
—
9
81
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
159
803
2.01
15.04
1.4
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2265
19754
1.27
14.76
4.2
3.8
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
161
826
1.98
14.58
2.6
2.4
g/l
0.0
0.0
0.50
145
762
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
186
1002
1.89
14.58
2.4
2.4
g/l
0.4
0.8
1.77
160
874
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
79
301
2.65
14.45
1.3
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
258
1541
1.71
14.33
4.1
3.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
174
923
1.92
14.30
2.5
2.2
g/l
38.9
38.1
1.03
151
799
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
169
888
1.93
14.29
2.5
2.3
g/l
0.0
0.0
0.82
153
818
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
79
303
2.63
14.27
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
79
303
2.63
14.27
1.3
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
522
3676
1.47
14.25
8.5
7.0
mmol/l
1.0
1.1
0.08
418
2859
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
534
3778
1.46
14.24
1.7
1.7
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
79
304
2.62
14.18
1.3
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
441
3006
1.51
14.14
9.0
7.7
g/l
121.2
120.7
0.22
432
2886
(40759836) Histone Ab [Presence] in Serum by Immunoblot
78
300
2.63
14.02
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
78
300
2.63
14.02
1.3
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
187
1024
1.86
13.95
1.3
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
158
819
1.96
13.91
2.6
2.4
g/l
0.0
0.0
0.00
145
760
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
535
3803
1.46
13.91
1.7
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
3798
35393
1.31
13.88
20.5
14.2
%
13.6
13.6
0.34
3734
34601
(3000570) Elastase.pancreatic [Mass/mass] in Stool
195
1100
1.80
13.23
1.4
1.4
ug/g
292.4
289.1
0.08
117
609
(40760888) Immunoglobulin light chains.free panel - Serum
132
656
2.04
13.10
3.1
3.5
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
514
3680
1.44
12.83
8.5
6.9
kpa
12.5
12.9
0.76
491
3507
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
514
3680
1.44
12.83
8.5
7.0
kpa
5.0
5.1
0.73
491
3508
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
174
957
1.85
12.82
3.4
4.4
mg/l
1.5
1.4
0.62
154
899
(3017446) Testosterone [Moles/volume] in Serum or Plasma
266
1652
1.64
12.76
2.9
2.0
nmol/l
9.9
10.7
0.87
231
1445
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
128
637
2.04
12.67
1.2
1.1
iu/ml
110.8
15507.4
0.59
34
165
(3008898) HLA-B27 [Presence]
254
1562
1.66
12.67
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
45
135
3.35
12.56
1.3
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
425
2948
1.48
12.50
3.6
3.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
413
2849
1.49
12.48
1.5
1.3
iu/l
25.9
28.1
0.62
345
2445
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
111
529
2.12
12.34
1.3
1.3
nmol/l
0.6
2.8
0.50
106
510
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
230
1388
1.69
12.33
4.3
3.7
mmol/l
24.8
24.9
0.23
215
1295
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
265
1661
1.63
12.27
5.2
4.3
mmol/l
24.1
24.2
0.20
245
1513
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
272
1717
1.62
12.23
10.2
9.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
175
981
1.81
12.15
2.6
2.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1987
17326
1.24
12.14
2.1
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
237
1448
1.67
12.13
1.8
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
118
580
2.06
12.10
1.5
1.6
—
—
—
0
0
(3036489) Thrombin time
244
1506
1.65
12.01
2.3
2.1
s
21.1
21.4
0.35
218
1288
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
302
1964
1.57
11.99
1.6
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
131
672
1.97
11.94
2.4
2.9
umol/l
31.5
34.3
0.99
111
575
(46235355) HIV 1 and 2 tests - Meaningful Use set
1148
9414
1.28
11.76
2.0
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
592
4419
1.39
11.62
2.8
2.6
umol/l
6.9
7.3
0.11
490
3783
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
73
299
2.46
11.59
1.3
1.2
—
—
—
0
0
(3010421) pH of Blood
162
902
1.82
11.52
3.0
3.6
ph
7.4
7.4
1.53
134
746
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
50
169
2.98
11.50
1.2
1.1
u/l
21.4
23.2
0.07
40
126
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
193
1132
1.73
11.50
1.9
2.0
ug/l
9.4
2.0
0.49
170
1002
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
505
3678
1.42
11.44
2.7
2.2
u/l
32.6
50.1
0.72
428
3109
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
97
454
2.16
11.32
1.4
1.3
pmol/l
355.9
367.3
0.05
72
359
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
102
487
2.12
11.32
1.2
1.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
213
1293
1.68
11.19
4.7
4.9
%
0.9
0.9
0.32
201
1199
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
305
2028
1.54
10.98
1.4
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
135
722
1.89
10.91
3.4
3.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
401
2829
1.45
10.81
3.0
2.6
e9/l
4.3
4.1
1.13
324
2284
(3000330) Specific gravity of Urine by Test strip
283
1858
1.55
10.79
3.9
3.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
80
354
2.28
10.72
3.1
2.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
147
813
1.83
10.71
1.5
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
121
628
1.95
10.70
1.4
1.2
u/ml
3.8
4.1
0.11
62
248
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
63
251
2.53
10.64
2.3
1.9
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
56
211
2.67
10.57
1.4
1.5
u/l
12.8
6.1
0.62
25
94
(3008757) Leukocyte morphology finding [Identifier] in Blood
76
331
2.32
10.57
3.0
3.9
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
49
172
2.87
10.57
1.2
1.1
u/l
83.3
79.8
0.08
41
132
(3015235) Bicarbonate [Moles/volume] in Capillary blood
140
766
1.85
10.56
3.9
2.9
mmol/l
24.8
24.9
0.18
126
671
(3004809) Band form neutrophils/100 leukocytes in Blood
98
475
2.08
10.48
3.2
3.2
%
0.8
1.6
3.78
77
383
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
137
747
1.86
10.45
1.5
1.4
u/ml
111.1
114.3
0.08
30
158
(3008152) Bicarbonate [Moles/volume] in Arterial blood
296
1979
1.53
10.40
7.6
6.7
mmol/l
24.4
24.5
0.26
282
1825
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
145
808
1.82
10.32
1.4
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
144
801
1.82
10.31
1.5
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
168
980
1.74
10.24
3.3
3.4
u/ml
0.4
0.4
0.47
101
555
(4268621)
92
440
2.11
10.20
2.4
2.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
206
1273
1.64
10.14
3.3
3.2
g/l
0.4
0.3
0.58
87
495
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
123
656
1.90
10.06
1.4
1.2
u/ml
3.0
2.4
0.18
52
203
(3012501) Base excess in Blood by calculation
137
757
1.83
10.03
2.9
3.7
mmol/l
2.1
2.5
1.38
89
498
(3011412) CD3 cells [#/volume] in Blood
73
320
2.30
10.02
2.0
2.2
e9/l
1.2
1.3
0.50
51
196
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
211
1316
1.63
10.01
1.5
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
181
1086
1.69
9.97
2.3
2.2
ug/l
239.6
632.3
1.17
158
1005
(3025941) Bacteria identified in Stool by Culture
342
2378
1.47
9.94
1.3
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
208
1300
1.63
9.80
4.4
4.8
%
1.6
1.6
0.08
197
1201
(3045683) HLA typing for celiac disease panel - Blood or Tissue
67
286
2.36
9.78
1.1
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
469
3464
1.39
9.77
4.4
3.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3257
30258
1.22
9.76
3.5
3.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
62
256
2.44
9.74
2.0
2.0
%
13.8
12.2
0.42
38
130
(3019060) Gas panel - Arterial blood
301
2049
1.50
9.73
5.1
4.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
616
4758
1.34
9.65
4.9
4.1
%
34.0
32.7
2.34
489
3260
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
192
1186
1.64
9.49
2.8
2.6
%
175.9
180.1
0.32
182
1127
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
67
291
2.32
9.42
3.7
6.7
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
19
37
5.15
9.35
1.1
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
105
545
1.95
9.34
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
132
738
1.81
9.33
2.3
2.1
g/l
130.5
129.7
0.17
88
549
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
198
1242
1.62
9.21
1.2
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
117
633
1.87
9.19
3.5
3.0
%
55.6
56.7
0.39
117
633
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
55
221
2.51
9.17
2.1
2.2
e9/l
0.2
0.2
0.02
47
180
(3014148) Varicella zoster virus Ab [Titer] in Serum
99
510
1.96
9.01
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
63
272
2.33
9.00
1.2
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
152
896
1.72
8.97
1.5
1.4
u/l
27.8
25.2
0.41
123
742
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
90
449
2.02
8.97
2.3
1.8
pmol/l
175.3
180.7
0.17
85
419
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
130
733
1.79
8.95
3.4
2.0
nmol/l
0.8
0.8
0.14
97
632
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
57
236
2.43
8.93
1.1
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
170
1035
1.67
8.91
5.2
5.7
mmol/l
1.3
1.2
0.49
155
906
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
152
899
1.71
8.87
1.3
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
368
2653
1.42
8.83
3.7
2.8
—
—
—
0
0
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
16
28
5.73
8.79
1.8
1.7
mg/l
1.3
1.0
0.13
11
22
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
16
28
5.73
8.79
1.8
1.7
mg/l
0.7
1.0
—
10
21
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
354
2537
1.43
8.78
2.3
2.2
u/l
4853.8
5806.8
0.23
138
1044
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
62
270
2.31
8.70
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
157
943
1.69
8.67
1.2
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
55
229
2.42
8.53
2.1
2.1
e6/l
398.9
596.0
2.26
46
181
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
11
13
8.48
8.46
1.2
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
63
280
2.27
8.44
3.8
3.2
%
55.4
58.3
0.42
41
195
(3024928) Oxygen saturation in Venous blood
124
703
1.78
8.41
3.2
3.3
—
—
—
0
0
(3036603) Volume of Urine
56
238
2.37
8.32
1.5
1.4
ml
1882.4
1969.2
0.14
18
45
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
268
1842
1.48
8.29
1.8
1.7
mg/l
3.4
3.5
0.11
207
1276
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
188
1196
1.59
8.29
2.9
2.6
g/l
3.6
3.6
0.26
179
1127
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
123
704
1.77
8.09
1.4
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
30
94
3.20
7.92
4.9
4.6
—
—
—
0
0
(4010399)
372
2739
1.39
7.91
1.4
1.4
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
57
252
2.28
7.76
1.0
1.1
nmol/l
8.5
6.0
—
9
47
(3003181) Sodium [Moles/volume] in Urine
108
603
1.81
7.74
1.4
1.4
mmol/l
60.6
65.2
0.61
90
491
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
153
945
1.64
7.64
1.6
1.5
nmol/l
0.4
0.4
0.01
121
751
(3017704) Immunofixation for Urine
40
151
2.66
7.62
1.5
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
71
346
2.07
7.60
1.1
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
196
1286
1.55
7.59
2.5
2.3
%
97.5
93.2
1.83
184
1183
(3006922) Hepatitis E virus Ab [Presence] in Serum
58
261
2.24
7.59
1.0
1.1
—
—
—
0
0
(4146454)
73
360
2.04
7.57
3.8
2.8
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
72
356
2.04
7.42
1.8
1.5
%
55.1
57.4
0.18
46
221
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
59
270
2.20
7.42
1.3
1.1
u/ml
45.0
33.8
—
6
8
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
33
114
2.91
7.41
1.2
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
112
641
1.76
7.41
1.1
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
154
963
1.62
7.33
1.4
1.3
mg/l
597.6
496.5
0.30
146
911
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
59
272
2.18
7.29
1.2
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
99
550
1.82
7.24
1.2
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
59
273
2.18
7.23
1.3
1.2
u/ml
32.0
14.4
0.52
12
13
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
11
7
15.75
7.22
1.4
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
37
139
2.67
7.14
1.2
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
284
2033
1.42
7.13
11.5
8.7
%
94.0
94.1
0.09
284
2024
(3044927) Protein electrophoresis panel - Urine
61
288
2.13
7.11
1.2
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
139
855
1.64
7.08
1.3
1.3
mmol/l
3.7
3.7
0.06
129
800
(3025468) Yersinia sp identified in Specimen by Organism specific culture
86
461
1.88
7.05
1.4
1.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
59
276
2.15
7.05
2.1
2.2
%
45.6
37.7
—
5
25
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
30
102
2.95
6.95
1.1
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
53
239
2.23
6.93
1.2
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
86
464
1.87
6.92
1.4
1.4
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
31
108
2.88
6.88
2.5
1.8
e6/l
180.0
203.4
0.15
21
59
(3005988) Vibrio sp identified in Specimen by Organism specific culture
86
465
1.86
6.87
1.4
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
70
353
2.00
6.87
10.7
4.4
mmol/l
7.7
7.1
0.46
55
289
(40768441) Liver Pathology biopsy report
58
273
2.14
6.83
1.3
1.4
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
56
260
2.17
6.83
1.3
1.1
u/ml
24.6
3.5
—
5
13
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
85
461
1.86
6.74
1.4
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
155
992
1.58
6.73
2.5
2.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
99
564
1.77
6.69
1.7
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
24
73
3.30
6.68
1.3
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
31
110
2.83
6.67
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
52
237
2.21
6.64
1.0
1.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
45
193
2.34
6.62
1.2
1.2
u/l
15.4
17.5
0.30
40
166
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
55
257
2.15
6.61
1.3
1.1
titre
302.5
196.3
0.32
12
32
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
118
709
1.68
6.60
1.1
1.1
u/ml
3.2
3.4
0.08
42
357
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
61
297
2.07
6.60
1.3
1.1
mg/l
34.8
34.0
0.05
49
251
(3021901) Oxygen saturation in Capillary blood
96
545
1.78
6.57
3.6
2.5
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
52
240
2.18
6.45
1.0
1.0
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
37
147
2.53
6.42
1.3
1.2
%
90.8
89.0
0.10
19
67
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
59
287
2.07
6.41
1.2
1.1
mg/l
212.0
231.5
0.40
52
255
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
85
471
1.82
6.32
1.4
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
465
3662
1.30
6.31
3.1
3.1
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
30
108
2.79
6.30
1.8
2.4
u/ml
1071.3
25547.5
—
6
19
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
58
286
2.04
6.09
1.2
1.2
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
46
207
2.23
6.09
1.8
1.5
nmol/l
2.0
4.1
0.97
35
164
(3028626) Oxygen [Partial pressure] in Capillary blood
128
803
1.61
6.08
3.7
3.2
kpa
8.8
8.7
0.14
119
746
(3039000) Anion gap in Blood
118
726
1.64
6.06
6.0
6.6
mmol/l
11.2
11.1
0.13
108
639
(3018572) Chloride [Moles/volume] in Blood
118
726
1.64
6.06
6.0
6.6
mmol/l
104.3
105.2
1.42
108
639
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
74
398
1.87
6.06
1.2
1.1
—
102.2
—
0
6
(3000475) Leukocytes [#/volume] in Synovial fluid
119
736
1.63
5.99
1.7
1.6
e6/l
6827.1
11611.5
1.62
86
530
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
21
63
3.34
5.99
1.6
1.4
ng/l
95.5
87.1
0.12
21
63
(21494755) Public health laboratory ask at order entry panel
369
4740
0.76
5.91
1.3
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
24
79
3.05
5.91
2.1
1.5
ug/l
9.2
8.8
0.17
24
79
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
84
475
1.78
5.87
1.1
1.1
g/l
1.5
1.5
0.03
73
431
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
103
619
1.68
5.81
1.5
1.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
134
860
1.57
5.81
1.4
1.4
e6/l
1307.5
5775.4
0.50
116
686
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
134
860
1.57
5.81
1.3
1.4
e6/l
43.8
23.0
0.40
112
644
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
14
32
4.38
5.76
1.1
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
40
174
2.31
5.75
2.6
2.5
%
44.8
42.7
0.22
18
55
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
121
760
1.61
5.74
1.2
1.1
au/ml
4.0
13.0
—
8
39
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
47
219
2.16
5.74
2.5
2.3
e6/l
624.0
699.1
0.16
14
80
(3028707) Methadone [Presence] in Urine by Screen method
137
887
1.56
5.72
2.5
2.7
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
25
86
2.92
5.72
1.6
1.2
mu/l
51.8
53.2
0.03
19
70
(3024522) Salmonella sp identified in Specimen by Organism specific culture
82
465
1.78
5.69
1.4
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
109
669
1.64
5.68
1.4
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
29
109
2.67
5.65
1.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
23
76
3.04
5.64
1.7
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
108
663
1.64
5.63
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
105
640
1.65
5.62
1.6
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
125
796
1.58
5.61
1.4
1.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
79
445
1.79
5.61
1.6
2.0
mg/l
25.9
26.1
0.01
20
122
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
25
87
2.88
5.61
1.4
1.6
nmol/l
0.2
0.2
0.57
20
65
(3036670) Protein [Mass/volume] in Synovial fluid
25
87
2.88
5.61
1.4
1.2
g/l
39.6
38.3
0.24
11
48
(3034426) Prothrombin time (PT)
34
139
2.46
5.60
1.4
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3817
36629
1.18
5.59
21.9
14.8
g/l
331.6
332.0
1.40
3791
36344
(3023511) Choriogonadotropin [Units/volume] in Urine
195
1366
1.44
5.58
1.5
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
269
1993
1.37
5.58
2.4
2.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
127
814
1.57
5.55
3.6
3.4
mg/l
18.3
24.0
1.21
75
500
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
36
153
2.36
5.46
1.2
1.1
%
94.5
89.6
0.51
19
70
(3016650) Hepatitis A virus Ab [Presence] in Serum
104
641
1.64
5.35
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
73
409
1.80
5.30
3.5
2.8
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
57
295
1.94
5.29
1.1
1.0
mg/l
325.4
292.2
1.63
47
271
(3040893) Potassium [Moles/volume] in Capillary blood
9
8
11.27
5.28
2.0
1.4
mmol/l
4.3
4.3
—
9
8
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
100
614
1.64
5.23
1.7
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
4073
39359
1.19
5.23
18.6
12.6
%
39.2
39.6
2.28
3000
30066
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
380
2991
1.29
5.20
2.8
2.4
ml/min/173m2
68.8
70.1
0.25
163
1145
(3010838) Calcium [Moles/time] in 24 hour Urine
43
202
2.14
5.18
1.5
1.7
mmol/24h
4.9
7.1
—
5
16
(3052851) Hemolysis interference index of Serum or Plasma
159
1088
1.48
5.16
2.6
3.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
144
966
1.51
5.15
5.2
4.0
mmol/l
3.8
3.8
0.92
131
911
(4027681)
48
236
2.04
5.14
1.4
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
61
328
1.87
5.06
1.3
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
14
36
3.90
4.98
5.3
11.6
mmol/l
5.7
5.6
0.01
14
36
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
50
253
1.99
4.96
1.2
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
15
41
3.67
4.92
1.3
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
29
118
2.47
4.86
3.0
2.6
—
—
—
0
0
(3020891) Body temperature
180
1277
1.42
4.86
5.0
4.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
33
143
2.32
4.83
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
33
143
2.32
4.83
1.3
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
76
446
1.71
4.75
1.2
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
39
183
2.14
4.74
1.5
2.2
ml
1922.7
1941.5
0.04
34
168
(3004775) Volume in Urine collected for unspecified duration
48
244
1.98
4.72
2.6
2.3
ml
696.5
611.4
0.70
37
163
(3035947) Staphylolysin Ab [Units/volume] in Serum
32
139
2.31
4.67
1.3
1.1
—
3.6
—
0
8
(40768446) Kidney Pathology biopsy report
30
127
2.37
4.64
2.2
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
228
1698
1.36
4.63
11.9
9.0
mmol/l
24.4
24.3
0.02
214
1598
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
39
186
2.11
4.56
1.3
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
11
25
4.41
4.56
1.4
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
48
250
1.93
4.43
1.5
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
32
143
2.25
4.40
1.3
1.5
—
—
—
0
0
(3016750) Collection duration of Urine
38
183
2.08
4.35
2.4
2.2
min
488.7
500.2
0.39
31
137
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
330
2617
1.28
4.30
1.1
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
43
218
1.98
4.29
1.1
1.1
u/l
1.0
1.1
0.39
18
112
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
39
192
2.04
4.22
1.3
1.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
46
241
1.92
4.19
1.2
1.5
ug/l
5.5
6.9
0.91
39
212
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
90
572
1.58
4.18
1.5
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
82
510
1.62
4.16
1.2
1.2
u/l
30.9
37.6
0.29
71
439
(40767503) Oxygen content in Capillary blood by calculation
107
709
1.52
4.13
2.8
2.3
%
16.6
16.6
0.03
51
339
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
23
91
2.53
4.12
1.7
1.6
ug/l
0.5
0.4
0.20
14
60
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
20
74
2.71
4.08
1.1
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
50
272
1.85
4.08
1.6
1.4
%
39.0
34.0
0.39
29
161
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
15
47
3.20
4.05
1.7
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
36
175
2.06
4.04
2.1
1.4
u/l
12.7
12.7
0.01
36
166
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
19
69
2.76
4.01
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
114
771
1.49
4.01
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
118
804
1.48
4.00
1.5
1.4
—
—
—
0
0
(4306422)
100
659
1.53
3.98
1.3
1.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
22
87
2.54
3.96
1.3
1.1
pmol/l
342.3
285.7
0.28
15
64
(3014765) Yersinia sp identified in Stool by Organism specific culture
164
1192
1.39
3.92
1.2
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
363
2946
1.25
3.92
1.2
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
31
144
2.16
3.91
1.1
1.1
ng/l
73.0
615.2
—
7
28
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
66
395
1.68
3.91
1.5
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
139
983
1.43
3.89
1.7
1.6
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
24
100
2.41
3.88
1.2
1.2
%
96.8
109.8
1.51
24
92
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
222
1697
1.32
3.84
1.7
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
70
429
1.64
3.80
1.5
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
116
797
1.47
3.79
1.5
1.6
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
16
55
2.92
3.73
1.1
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
16
55
2.92
3.73
1.1
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
51
288
1.78
3.72
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
112
771
1.46
3.64
1.1
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
56
328
1.72
3.61
1.1
1.1
nmol/l
382.8
380.3
0.03
46
294
(3019977) pH of Arterial blood
33
163
2.03
3.59
3.8
3.4
ph
7.4
7.4
—
10
49
(3003888) Timothy IgE Ab [Units/volume] in Serum
134
957
1.41
3.58
1.1
1.1
u/ml
2.2
5.8
4.70
62
494
(4034850)
175
1308
1.35
3.55
10.4
8.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
22
92
2.40
3.55
4.8
3.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
22
92
2.40
3.55
4.8
3.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
33
164
2.02
3.54
1.1
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
48
271
1.78
3.52
1.5
1.3
e6/l
55340.3
101917.7
0.41
36
188
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
16
57
2.81
3.52
1.5
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
115
802
1.44
3.51
2.4
2.2
umol/l
6.0
5.3
0.47
87
583
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
160
1182
1.37
3.51
1.2
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
9
17
5.30
3.50
3.4
6.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
153
1123
1.37
3.49
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
41
221
1.86
3.49
1.4
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
27
125
2.17
3.47
1.1
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
86
570
1.52
3.39
1.5
1.7
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
64
396
1.62
3.38
7.1
6.3
mg/l
11.6
11.4
0.10
58
365
(42529406) Shigella sp [Presence] in Stool by Culture
161
1200
1.35
3.35
1.2
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
53
313
1.70
3.34
1.3
1.2
u/ml
0.2
0.9
1.01
21
127
(3000492) Spirometry study
469
3979
1.20
3.32
1.5
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
47
269
1.75
3.31
2.6
3.4
%
11.4
10.9
0.48
47
269
(4015189)
19
77
2.47
3.29
2.5
2.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
144
1058
1.37
3.29
1.1
1.1
u/ml
1.6
1.8
0.11
52
413
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
605
5253
1.17
3.27
1.5
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
123
881
1.41
3.27
1.0
1.1
u/ml
1.7
2.0
0.11
19
211
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
60
369
1.63
3.26
1.2
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
62
385
1.62
3.25
1.8
1.5
mosm/kgh2o
281.0
279.4
0.23
52
305
(3016038) Potassium [Moles/volume] in Urine
41
227
1.81
3.23
1.1
1.2
mmol/l
29.3
35.0
1.06
34
203
(3014271) Vancomycin [Susceptibility]
29
143
2.03
3.20
2.8
2.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
58
356
1.64
3.19
1.5
1.7
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
7
11
6.37
3.18
1.0
1.2
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
45
258
1.75
3.17
2.2
1.4
—
67.6
—
0
24
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
15
55
2.73
3.15
1.8
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
30
151
1.99
3.14
1.1
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
34
179
1.91
3.13
1.3
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
34
179
1.91
3.13
1.3
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
34
179
1.91
3.13
1.3
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
34
179
1.91
3.13
1.3
1.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
126
917
1.38
3.07
1.1
1.1
u/ml
0.3
1.0
2.81
55
383
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
8
16
5.01
3.05
4.5
2.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
13
45
2.89
3.02
1.2
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
22
100
2.21
2.99
1.0
1.6
—
—
—
0
0
(4211845)
37
204
1.82
2.98
3.4
3.0
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
5
5
10.01
2.98
8.4
1.4
mg/l
34.4
130.4
—
5
5
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
105
745
1.42
2.97
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
105
745
1.42
2.97
1.2
1.3
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
25
120
2.09
2.97
2.7
2.6
umol/l
29.1
29.5
0.05
14
90
(3000012) Reticulocyte production index
34
184
1.85
2.91
1.7
1.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
52
2.70
2.88
7.6
4.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
109
784
1.40
2.87
1.5
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
48
289
1.67
2.87
1.5
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
48
289
1.67
2.87
1.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
48
289
1.67
2.87
1.5
1.6
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
7
13
5.39
2.87
6.0
5.5
umol/l
397.1
373.6
—
7
13
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
49
297
1.66
2.86
3.9
4.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
33
178
1.86
2.86
1.8
2.2
ug/min
44.1
180.8
1.20
11
32
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
62
399
1.56
2.84
1.6
1.4
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
46
276
1.67
2.79
13.5
11.2
mmol/l
0.7
0.6
0.93
41
249
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
29
151
1.93
2.79
2.7
2.4
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
9
23
3.92
2.77
1.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
608
5355
1.15
2.74
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
35
196
1.79
2.71
1.2
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
53
333
1.60
2.70
1.4
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
33
182
1.82
2.68
3.5
3.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
33
183
1.81
2.64
1.6
2.4
e9/l
0.1
0.4
0.76
33
174
(21494890) Protein electrophoresis panel - 24 hour Urine
46
281
1.64
2.63
1.6
2.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
48
297
1.62
2.61
1.5
1.4
mmol/l
2.0
2.0
0.21
43
278
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
96
689
1.40
2.59
1.3
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
7
15
4.67
2.59
1.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
64
425
1.51
2.58
1.5
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
11
38
2.90
2.58
1.8
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
226
1834
1.24
2.55
1.9
1.8
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
27
142
1.91
2.55
1.7
1.3
%
6.3
4.7
—
7
28
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
366
4281
0.84
2.55
1.7
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
564
4971
1.15
2.53
4.9
4.6
ug/l
3.2
2.6
0.28
504
4415
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
153
1185
1.30
2.53
3.1
3.4
u/ml
229.6
1499.4
0.85
124
1009
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
37
216
1.72
2.51
1.3
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
55
356
1.55
2.50
1.4
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
56
364
1.54
2.50
1.1
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
16
69
2.32
2.48
1.7
1.9
—
—
—
0
0
(3048879) Bone marrow aspiration report
17
76
2.24
2.43
1.4
2.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
21
103
2.04
2.41
1.6
2.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
78
550
1.42
2.36
3.3
3.1
nmol/l
0.8
0.8
0.06
62
416
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
30
168
1.79
2.36
1.3
1.2
g/l
0.3
0.3
0.36
24
135
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
50
323
1.55
2.32
1.1
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
15
65
2.31
2.31
2.8
2.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
24
126
1.91
2.30
5.5
4.2
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
14
59
2.38
2.29
1.9
1.9
mmol/l
1.4
1.9
—
9
43
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
12
47
2.56
2.27
1.2
1.2
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
8
23
3.48
2.27
1.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
64
439
1.46
2.25
1.5
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
35
210
1.67
2.19
1.2
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
8
24
3.34
2.18
1.5
1.0
—
—
—
0
0
(4094501)
126
973
1.30
2.18
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
249
2967
0.83
2.17
1.4
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
25
136
1.84
2.17
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
110
835
1.32
2.15
1.9
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
74
528
1.41
2.13
2.4
2.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
23
123
1.87
2.11
1.0
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
15
68
2.21
2.10
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
15
68
2.21
2.10
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
15
68
2.21
2.10
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
15
68
2.21
2.10
1.1
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
48
315
1.53
2.10
1.0
1.0
u/ml
0.3
1.3
0.73
14
99
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
20
102
1.96
2.10
1.1
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
5
10
5.00
2.07
1.4
4.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
9
31
2.91
2.07
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
215
1780
1.22
2.07
1.8
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1640
15492
1.09
2.07
3.2
2.5
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
20
103
1.95
2.05
1.3
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
20
103
1.95
2.05
1.2
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
16
76
2.11
2.02
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
23
125
1.84
2.02
2.3
2.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
26
147
1.77
2.02
1.0
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
93
697
1.34
2.00
1.1
1.1
u/ml
11.1
3.9
0.33
25
269
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
68
485
1.41
1.98
1.6
1.4
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
120
935
1.29
1.97
1.4
1.3
ug/l
3.9
4.1
0.07
106
850
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
44
288
1.53
1.97
1.3
1.4
nmol/l
1.3
1.5
0.43
38
255
(21494814) CD8 cells/100 lymphocytes in Specimen
22
119
1.85
1.96
1.5
2.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
223
1864
1.21
1.96
2.1
2.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
25
141
1.78
1.96
1.2
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
27
156
1.73
1.96
20.7
27.8
ug/l
118.4
116.8
0.05
18
126
(3014133) Dog dander IgE Ab [Units/volume] in Serum
100
761
1.32
1.95
1.1
1.0
u/ml
3.4
3.5
0.03
27
283
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
34
210
1.62
1.94
1.2
1.1
u/ml
1.8
8.9
—
6
18
(3022475) Manganese [Moles/volume] in Blood
8
27
2.97
1.93
1.1
1.4
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
16
3.75
1.93
1.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
45
2.45
1.93
1.4
1.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
11
45
2.45
1.93
2.5
2.5
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
39
2.57
1.92
1.2
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
57
397
1.44
1.90
1.5
1.4
mmol/l
10.7
11.2
0.15
13
66
(3036048) Francisella tularensis Ab [Titer] in Serum
17
85
2.00
1.90
1.2
1.1
—
253.3
—
0
6
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
56
390
1.44
1.87
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
67
483
1.39
1.86
1.2
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
32
198
1.62
1.83
1.3
1.3
nmol/l
150.7
134.1
0.84
32
198
(44790047)
56
394
1.43
1.79
1.5
1.4
—
—
—
0
0
(44790048)
56
394
1.43
1.79
1.5
1.4
—
—
—
0
0
(44790049)
56
394
1.43
1.79
1.5
1.4
—
—
—
0
0
(44806118)
56
394
1.43
1.79
1.5
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
238
2021
1.19
1.79
2.1
2.1
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
11
47
2.34
1.77
3.3
3.0
—
11.3
—
0
9
(3019174) dRVVT (LA screen)
10
41
2.44
1.75
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
69
506
1.37
1.75
1.4
1.4
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
6
18
3.34
1.74
3.7
6.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
31
193
1.61
1.74
2.3
1.5
nmol/l
1.2
1.3
0.12
26
152
(1001926) Buprenorphine [Presence] in Urine by Screen method
188
1568
1.21
1.73
2.1
2.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
20
110
1.82
1.72
1.6
1.8
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
22
125
1.76
1.71
1.5
2.1
%
8.5
8.7
0.03
22
119
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
19
103
1.85
1.71
1.2
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
36
234
1.54
1.70
1.6
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
86
656
1.32
1.69
1.7
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
47
324
1.45
1.69
3.1
2.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
14
268
0.52
1.68
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
57
408
1.40
1.67
1.5
1.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
19
104
1.83
1.67
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
53
375
1.42
1.66
1.5
1.6
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
19
3.16
1.66
1.3
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
25
150
1.67
1.63
1.2
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
237
2032
1.17
1.62
2.1
2.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
35
229
1.53
1.62
1.2
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
13
63
2.07
1.59
4.8
7.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
55
396
1.39
1.58
3.6
2.8
—
—
—
0
0
(4024509)
57
413
1.38
1.58
1.8
1.6
—
—
—
0
0
(3025315) Body weight
7
26
2.69
1.58
4.9
4.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
21
121
1.74
1.58
1.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
237
2037
1.17
1.58
2.1
2.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
11
50
2.20
1.56
2.9
1.9
—
—
—
0
0
(4198724)
34
223
1.53
1.56
2.7
2.9
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
36
240
1.50
1.54
1.4
1.9
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
28
176
1.59
1.54
2.7
2.3
umol/l
67.4
50.2
1.63
23
146
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
15
78
1.93
1.54
1.1
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
89
693
1.29
1.53
2.9
3.4
u/ml
1013.2
742.2
0.10
76
629
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
414
3709
1.13
1.53
3.2
3.9
ug/l
52.3
26.0
0.49
316
2893
(1002224) Polysomnography panel
205
1748
1.18
1.51
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
43
299
1.44
1.50
1.9
2.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
12
58
2.07
1.49
1.4
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
17
94
1.81
1.47
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
40
276
1.45
1.46
1.4
1.4
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
16
3.13
1.44
2.0
8.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
24
148
1.62
1.44
1.2
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
24
148
1.62
1.44
1.3
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
24
148
1.62
1.44
1.3
1.9
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
22
2.73
1.43
1.3
3.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
40
279
1.44
1.39
1.2
1.1
ratio
1.0
1.0
0.41
19
102
(3042517) Benzodiazepines panel - Urine
10
46
2.18
1.39
3.6
2.3
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
28
181
1.55
1.39
1.8
2.7
umol/l
83.4
147.8
1.38
11
98
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
12
225
0.53
1.39
1.3
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
17
96
1.77
1.38
1.1
1.1
—
—
—
0
0
(4281824)
38
539
0.70
1.37
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
38
264
1.44
1.36
1.3
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
34
231
1.48
1.36
2.9
3.5
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
5
17
2.94
1.36
1.4
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
23
143
1.61
1.35
1.1
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
17
97
1.76
1.34
1.1
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
8
34
2.35
1.29
1.1
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
18
2.78
1.28
1.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
13
69
1.89
1.28
4.5
7.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
8
35
2.29
1.26
2.6
2.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
43
311
1.39
1.25
1.1
1.1
iu/ml
9.7
8.8
0.07
11
85
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
23
146
1.58
1.25
2.1
3.8
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
24
154
1.56
1.25
1.0
1.1
u/ml
0.1
8.0
—
9
92
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
40
286
1.40
1.25
2.1
2.0
u/field
2.0
2.0
0.03
17
125
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
25
2.40
1.24
2.0
2.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
25
2.40
1.24
1.0
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
200
1735
1.16
1.24
1.3
1.3
miu/ml
232.4
231.2
0.02
99
877
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
8
36
2.22
1.24
1.6
2.5
u/field
1.0
0.6
—
8
36
(3037556) Urate [Mass/volume] in Serum or Plasma
17
100
1.70
1.23
1.2
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
48
357
1.35
1.19
1.5
1.8
—
—
—
0
0
(4035726)
378
3426
1.11
1.19
1.4
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
29
197
1.47
1.19
1.8
1.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
6
26
2.31
1.18
1.5
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
128
1518
0.84
1.18
1.7
1.8
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
34
239
1.43
1.17
1.7
1.5
u/ml
16.3
20.0
—
7
49
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
125
1.60
1.17
1.1
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
11
57
1.93
1.17
2.8
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
67
526
1.28
1.15
1.6
1.7
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
8
39
2.05
1.15
1.3
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
39
2.05
1.15
1.1
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
20
2.50
1.15
3.8
6.3
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
20
2.50
1.15
1.0
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
13
72
1.81
1.15
2.6
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
45
334
1.35
1.14
3.3
2.6
mg/l
69.1
45.1
0.25
32
236
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
501
4620
1.09
1.13
6.8
6.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
114
953
1.20
1.12
2.0
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
227
2005
1.14
1.12
2.1
2.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
11
58
1.90
1.12
1.0
2.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
73
909
0.80
1.11
2.0
3.8
u/ml
18.4
30.8
2.15
68
884
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
43
320
1.35
1.09
1.2
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
12
66
1.82
1.08
1.2
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
78
633
1.24
1.04
1.1
1.0
u/ml
0.5
0.3
0.24
14
134
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
40
297
1.35
1.04
1.3
1.4
mmol/l
5.2
5.5
0.97
35
284
(3006576) Bicarbonate [Moles/volume] in Blood
15
90
1.67
1.03
4.7
6.1
mmol/l
23.8
25.2
0.45
15
84
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
22
2.27
1.03
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
22
2.27
1.03
1.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
16
98
1.63
1.03
1.3
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
432
3979
1.09
1.02
4.2
4.0
%
21.3
21.4
0.02
206
1806
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
28
196
1.43
1.02
1.9
1.7
u/field
1.5
2.8
0.94
19
142
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
35
2.00
1.00
1.3
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
25
172
1.46
0.99
1.4
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
25
172
1.46
0.99
1.4
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
632
5924
1.08
0.98
1.6
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
544
5070
1.08
0.98
1.8
1.7
%
1.4
1.4
0.70
493
4519
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
14
84
1.67
0.97
1.6
2.8
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
21
140
1.50
0.97
7.7
10.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
7
36
1.95
0.97
1.1
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
40
301
1.33
0.97
1.5
1.4
e6/l
58843.4
40981.0
0.23
24
174
(3004716) Salmonella sp identified in Stool by Organism specific culture
274
2478
1.11
0.95
1.5
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
21
141
1.49
0.94
1.1
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
27
2.22
0.93
1.8
1.8
umol/l
60.2
40.6
—
6
27
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
17
109
1.56
0.93
1.4
1.1
u/ml
59.3
51.2
0.26
17
103
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
52
1.73
0.92
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
20
134
1.49
0.91
1.2
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
42
322
1.31
0.91
1.9
2.0
mmol/l
8.1
6.1
1.52
27
232
(3023199) Leukocytes [#/volume] in Pleural fluid
44
340
1.30
0.90
1.4
1.4
e6/l
2005.0
2441.9
0.29
31
247
(3008536) Aspergillus sp Ab [Presence] in Serum
11
63
1.75
0.90
1.5
2.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
29
2.07
0.89
1.0
1.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
13
79
1.65
0.88
1.1
1.1
umol/24h
0.7
0.7
—
6
47
(3009466) Valproate [Moles/volume] in Serum or Plasma
66
539
1.23
0.87
5.6
5.3
umol/l
372.5
375.1
0.05
55
469
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
26
186
1.40
0.87
1.1
1.0
miu/ml
1547.8
1537.0
0.02
26
186
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
6
30
2.00
0.87
1.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
93
786
1.19
0.87
1.2
1.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
42
325
1.29
0.86
1.0
1.0
u/ml
0.3
0.6
—
6
81
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
44
1.82
0.85
6.5
7.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
37
282
1.31
0.84
1.3
1.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
8
45
1.78
0.84
2.6
2.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
37
284
1.31
0.81
1.7
1.6
promille
1.2
1.2
0.08
31
222
(3011288) Drugs identified in Urine by Screen method
157
1390
1.13
0.81
3.6
2.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
22
155
1.42
0.81
1.6
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
19
271
0.70
0.80
1.9
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
36
277
1.30
0.78
1.4
2.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
22
156
1.41
0.78
1.9
2.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
457
4280
1.07
0.77
2.0
1.8
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
6
34
1.77
0.76
1.0
1.1
—
2.1
—
0
9
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
183
1.37
0.75
1.6
1.4
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
5
25
2.00
0.72
1.6
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
14
92
1.52
0.72
1.1
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
17
117
1.45
0.71
1.2
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
36
282
1.28
0.70
1.2
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
22
160
1.38
0.70
1.6
1.5
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
7
41
1.71
0.70
1.0
1.2
—
552.0
—
0
8
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
58
1.55
0.69
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
103
899
1.15
0.69
1.7
1.6
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
21
285
0.74
0.68
1.4
1.3
—
1.5
—
0
16
(3026726) Creatinine [Moles/volume] in Specimen
5
27
1.85
0.68
1.8
2.0
umol/l
258.4
779.8
—
5
27
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
5
27
1.85
0.68
1.2
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
9
59
1.53
0.68
14.7
5.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
18
127
1.42
0.67
1.2
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
20
144
1.39
0.67
1.2
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
28
214
1.31
0.66
1.3
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
633
6029
1.06
0.65
2.1
2.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
7
44
1.59
0.65
1.4
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
22
163
1.35
0.64
1.4
1.3
pmol/l
50.4
222.0
0.53
11
57
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
13
87
1.50
0.63
1.1
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
11
71
1.55
0.62
1.5
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
569
5417
1.06
0.61
1.9
1.9
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1028
9948
1.04
0.57
1.5
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
34
275
1.24
0.55
1.2
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
12
82
1.46
0.54
1.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
12
82
1.46
0.54
1.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
12
82
1.46
0.54
1.0
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
45
377
1.20
0.53
2.9
3.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
15
108
1.39
0.53
2.1
1.3
—
—
—
0
0
(4133840)
13
91
1.43
0.53
1.6
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
154
1681
0.91
0.51
1.5
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
30
243
1.24
0.49
1.2
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
7
45
1.56
0.49
1.3
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
20
154
1.30
0.48
1.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
46
1.52
0.48
1.4
2.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
47
1.49
0.47
1.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
7
48
1.46
0.46
1.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
40
472
0.85
0.46
1.5
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
36
301
1.20
0.45
1.8
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
7
50
1.40
0.45
1.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
86
1.40
0.44
1.1
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
25
202
1.24
0.43
1.0
1.0
ng/l
330.5
339.3
0.05
15
145
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
5
32
1.56
0.42
1.0
1.0
—
0.1
—
0
16
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
25
203
1.23
0.42
1.0
1.0
ng/l
891.8
716.5
0.77
14
142
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
0
16
0.00
0.41
0.0
1.5
—
51.9
—
0
11
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
5.1
—
2.0
—
0
11
(3009677) Dengue virus Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1294
12665
1.03
0.39
1.6
1.6
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
103
0.68
0.39
1.1
2.0
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
61
541
1.13
0.39
1.7
1.6
mmol/l
7.6
7.5
0.14
42
336
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
16
124
1.29
0.38
1.1
1.1
%
23.2
22.4
—
6
13
(44806420)
11
80
1.38
0.38
1.8
2.3
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
5
36
1.39
0.38
1.2
1.1
—
—
—
0
0
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
5
36
1.39
0.38
1.0
1.0
u/ml
9.2
11.7
—
5
26
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
25
206
1.21
0.37
1.0
1.0
ng/l
47.0
46.0
0.03
15
146
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
28
333
0.84
0.37
1.6
1.4
g/l
1.0
1.0
0.06
28
333
(40768793) Breast Pathology biopsy report
115
1243
0.92
0.35
1.2
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
14
108
1.30
0.35
1.8
2.2
umol/l
12.1
17.1
1.06
14
108
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
43
1.40
0.35
1.0
3.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
32
273
1.17
0.35
1.4
1.5
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
46
1.30
0.33
1.5
1.1
—
—
—
0
0
(44813793)
40
350
1.14
0.32
1.1
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
122
1308
0.93
0.31
1.5
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
28
327
0.86
0.31
1.4
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
53
1.32
0.30
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
75
1.33
0.30
1.1
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
694
6770
1.03
0.29
2.2
2.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
17
139
1.22
0.29
1.8
2.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
88
814
1.08
0.28
1.6
1.7
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
8
62
1.29
0.28
1.0
1.0
—
—
—
0
0
(44806071)
8
65
1.23
0.27
1.1
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
36
406
0.89
0.27
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
42
378
1.11
0.24
1.3
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
304
2937
1.04
0.24
2.9
3.4
u/ml
67.2
52.1
0.37
294
2833
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
344
3334
1.03
0.23
1.8
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
173
1653
1.05
0.23
2.4
1.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
147
1543
0.95
0.22
1.5
1.5
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
14
116
1.21
0.22
1.5
1.8
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
28
248
1.13
0.21
1.8
1.8
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(37019676) Renin [Units/volume] in Plasma --supine
0
11
0.00
0.21
0.0
1.0
—
13.6
—
0
6
(3002079) Sodium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
118.0
—
0
10
(3041184) Isoniazid [Presence] in Urine
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
105
0.76
0.21
1.1
1.1
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
0
13
0.00
0.21
0.0
1.4
—
23.6
—
0
5
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
14
117
1.20
0.20
1.3
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
30
269
1.12
0.19
1.2
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
14
165
0.85
0.19
1.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
144
1500
0.96
0.18
1.5
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
301
2930
1.03
0.17
3.0
2.9
ug/l
0.7
0.7
0.57
200
1825
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
63
1.11
0.17
1.1
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
71
670
1.06
0.16
1.3
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
20
177
1.13
0.16
2.3
3.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
144
1493
0.96
0.15
1.5
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
237
2308
1.03
0.14
1.4
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
32
347
0.92
0.14
1.7
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
13
149
0.87
0.13
2.1
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
344
3503
0.98
0.12
1.5
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
16
143
1.12
0.11
1.1
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
45
1.11
0.09
1.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
46
1.09
0.09
1.0
1.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
47
1.06
0.09
2.6
3.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
47
1.06
0.09
5.2
6.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
48
1.04
0.09
1.4
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
6
55
1.09
0.08
6.0
5.9
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
14
154
0.91
0.08
1.4
1.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
7
65
1.08
0.08
1.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
70
0.86
0.07
1.5
1.8
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
9
84
1.07
0.07
1.1
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
9
88
1.02
0.07
1.1
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
181
1840
0.98
0.07
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
181
1839
0.98
0.06
1.4
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
81
830
0.98
0.06
1.2
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
36
346
1.04
0.05
1.6
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
31
297
1.04
0.05
1.3
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
181
1833
0.99
0.05
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
181
1832
0.99
0.04
1.4
1.4
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
14
150
0.93
0.04
2.1
2.3
mmol/l
12.2
9.5
—
9
118
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
201
1990
1.01
0.04
1.5
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
17
162
1.05
0.02
2.3
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
16
153
1.05
0.01
1.4
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
207
2063
1.00
0.00
1.4
1.4
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
23
236
0.97
0.00
3.6
2.7
—
26.4
—
0
5
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
209
2084
1.00
0.00
1.4
1.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
10
95
1.05
0.00
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
10
105
0.95
0.00
1.2
2.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
12
115
1.04
0.00
1.5
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
40
405
0.99
0.00
1.2
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
67
669
1.00
0.00
3.9
2.2
%
13.0
13.1
0.27
67
661
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
73
731
1.00
0.00
1.5
1.4
mmol/l
6.6
7.1
0.83
48
533
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
49
1.02
0.00
1.0
1.1
umol/24h
1.2
1.6
—
5
49
(3007919) Fasciola sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
7
74
0.95
0.00
1.7
1.3
%
21.8
22.2
—
7
67
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
8
86
0.93
0.00
1.9
1.3
mmol/l
4.9
3.1
—
8
77
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
38.6
—
0
5
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
8
0.00
0.00
0.0
1.1
—
41.2
—
0
8
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
62
0.97
0.00
1.7
1.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
20
200
1.00
0.00
1.4
1.6
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
1.0
—
0.8
—
0
5
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
9
0.00
0.00
0.0
1.6
—
2399.8
—
0
9

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: THYROIDITIS_ILD – Thyroiditis, ILD-related definition

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).